Asta Funding (ASFI) 10-Q/A 18 Sep 18 2017 Q3 Quarterly report (amended) Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Jun. 30, 2017	Aug. 14, 2018
Document Information [Line Items]
Entity Registrant Name	ASTA FUNDING INC
Entity Central Index Key	1,001,258
Trading Symbol	asfi
Current Fiscal Year End Date	--09-30
Entity Filer Category	Accelerated Filer
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		6,685,415
Document Type	10-Q/A
Document Period End Date	Jun. 30, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q3
Amendment Flag	true
Amendment Description	As previously disclosed in the Current Report on Form 8-K filed by Asta Funding, Inc. ("Asta" or the "Company") with the Securities and Exchange Commission (the "SEC") on January 18, 2018, the Board of Directors (the "Board") of the Company, upon the recommendation of the Audit Committee of the Board (the "Audit Committee"), determined that the Company's previously issued financial statements for each of the years ended September 30, 2016, 2015 and 2014, and the interim periods contained therein, as well as the Company's unaudited consolidated financial statements for the quarters ended December 31, 2016, March 31, 2017 and June 30, 2017, could no longer be relied upon. On September 17, 2018, the Company filed an Annual Report on Form 10-K/A (the "Form 10-K/A") to amend and restate the Company's previously issued financial statements for each of the years ended September 30, 2016, 2015 and 2014, as well as the interim periods contained therein, and Quarterly Reports on Form 10-Q/A to amend and restate the Company's previously issued financial statement for the quarters ended December 31, 2016 and March 31, 2017. The Company is filing this Amendment No. 1 on Form 10-Q/A (this "Amendment") to amend and restate the Company's previously issued financial statements contained in its Quarterly Report on Form 10-Q for the quarter ended June 30, 2017 (the "Non-Reliance Period"), which was originally filed with the SEC on August 9, 2017 (the "Original Form 10-Q"). Prior period amounts have already been restated in the Company's Form 10-K/A and, accordingly have not been restated in this Amendment.

Consolidated Balance Sheets (Cu

Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Jun. 30, 2017	Sep. 30, 2016
ASSETS
Cash and cash equivalents	$ 15,213,000	$ 6,282,000
Restricted cash	10,000,000	10,000,000
Available for sale investments (at fair value)	5,500,000	56,763,000
Consumer receivables acquired for liquidation (at net realizable value)	9,210,000	13,427,000
Investment in personal injury claims	3,351,000
Other investments, net		3,590,000
Due from third party collection agencies and attorneys	1,357,000	1,050,000
Prepaid and income taxes receivable	6,736,000	714,000
Furniture and equipment, net	141,000	196,000
Equity method investment	48,533,000	48,582,000
Deferred income taxes	14,120,000	14,903,000
Goodwill	1,410,000	1,410,000
Other assets	3,408,000	6,585,000
Assets related to discontinued operations	93,692,000	91,506,000
Total assets	212,671,000	255,008,000
LIABILITIES
Line of credit	9,600,000
Other liabilities	5,249,000	3,987,000
Liabilities related to discontinued operations	78,629,000	69,238,000
Total liabilities	93,478,000	73,225,000
Commitments and contingencies
STOCKHOLDERS’ EQUITY
Preferred stock
Common stock, $.01 par value, authorized 30,000,000 shares; issued 13,398,108 at June 30, 2017 and 13,336,508 at September 30, 2016; and outstanding 6,623,815 at June 30, 2017 and 11,876,224 at September 30, 2016	134,000	133,000
Additional paid-in capital	68,027,000	67,034,000
Retained earnings	117,949,000	126,738,000
Accumulated other comprehensive income	211,000	803,000
Treasury stock (at cost) 6,774,293 shares at June 30, 2017 and 1,460,284 shares at September 30, 2016	(67,128,000)	(12,925,000)
Total stockholders’ equity	119,193,000	181,783,000
Total liabilities and stockholders’ equity	212,671,000	255,008,000
Series A Junior Participating Preferred Stock [Member]
STOCKHOLDERS’ EQUITY
Preferred stock

Consolidated Balance Sheets (C3

Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Jun. 30, 2017	Sep. 30, 2016
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, authorized (in shares)	5,000,000	5,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, authorized (in shares)	30,000,000	30,000,000
Common stock, issued (in shares)	13,398,108	13,336,508
Common stock, outstanding (in shares)	6,623,815	11,876,224
Treasury stock, shares (in shares)	6,774,293	1,460,284
Series A Junior Participating Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, authorized (in shares)	30,000	30,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Revenues:
Finance income, net	$ 3,993,000	$ 4,572,000	$ 12,018,000	$ 14,557,000
Personal injury claims income	241,000		251,000
Disability fee income	1,134,000	1,169,000	3,990,000	2,700,000
Total revenues	5,368,000	5,741,000	16,259,000	17,257,000
Other income (loss) - includes ($18,000) and ($32,000) during the three month periods ended June 30, 2017 and 2016, and ($1,011,000) and ($63,000) during the nine month periods ended June 30, 2017 and 2016, respectively, of accumulated other comprehensive loss reclassification for securities sold	90,000	176,000	(126,000)	1,176,000
	5,458,000	5,917,000	16,133,000	18,433,000
Expenses:
General and administrative	6,066,000	7,069,000	25,611,000	23,020,000
Interest	164,000		197,000
Impairment of consumer receivables	148,000		148,000	124,000
Earnings from equity method investment	(2,710,000)	(6,193,000)	(2,759,000)	(6,193,000)
	3,668,000	876,000	23,197,000	15,124,000
Income (loss) from continuing operations before income tax	1,790,000	5,041,000	(7,064,000)	3,309,000
Income tax (benefit)/expense - includes tax expense/(benefit) of $7,000 and ($13,000) during the three month periods ended June 30, 2017 and 2016 and $404,000 and ($24,000) during the nine month periods ended June 30, 2017 and 2016, respectively, of accumulated other comprehensive income reclassifications for unrealized net gains / (losses) on available for sale securities	219,000	1,752,000	(31,000)	1,114,000
Net income (loss) from continuing operations	1,571,000	3,289,000	(7,033,000)	2,195,000
Net income (loss) from discontinued operations, net of income tax	560,000	577,000	(1,756,000)	1,404,000
Net income (loss)	$ 2,131,000	$ 3,866,000	$ (8,789,000)	$ 3,599,000
Net income (loss) per basic shares:
Continuing operations (in dollars per share)	$ 0.24	$ 0.27	$ (0.75)	$ 0.18
Discontinued operations (in dollars per share)	0.08	0.05	(0.19)	0.12
(in dollars per share)	0.32	0.32	(0.94)	0.30
Net income (loss) per diluted shares:
Continuing operations (in dollars per share)	0.23	0.26	(0.75)	0.18
Discontinued operations (in dollars per share)	0.08	0.05	(0.19)	0.11
(in dollars per share)	$ 0.31	$ 0.31	$ (0.94)	$ 0.29
Weighted average number of common shares outstanding:
Basic (in shares)	6,577,784	11,897,139	9,389,864	12,023,156
Diluted (in shares)	6,879,082	12,433,424	9,389,864	12,294,073

Consolidated Statements of Ope5

Consolidated Statements of Operations (Unaudited) (Parentheticals) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Reclassification for unrealized net gain (loss) on available for sale securities	$ (18,000)	$ (32,000)	$ (1,011,000)	$ (63,000)
Income tax (benefit) expense	$ 7,000	$ (13,000)	$ 404,000	$ (24,000)

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Comprehensive income (loss) is as follows:
Net income (loss)	$ 2,131,000	$ 3,866,000	$ (8,789,000)	$ 3,599,000
Net unrealized securities gain (loss), net of tax (expense)/benefit of $(12,000) and ($364,000) during the three month periods ended June 30, 2017 and 2016, respectively, and $11,000 and ($695,000) during the nine month periods ended June 30, 2017 and 2016, respectively.	18,000	560,000	(17,000)	1,046,000
Reclassification adjustments for securities sold, net of tax benefit of $7,000 and $13,000 during the three month periods ended June 30, 2017 and 2016, and $404,000 and $24,000 during the nine month periods ended June 30, 2017 and 2016, respectively.	(11,000)	(19,000)	(607,000)	(39,000)
Foreign currency translation, net of tax (expense)/benefit of ($23,000) and $15,000 during the three month periods ended June 30, 2017 and 2016, respectively, and ($21,000) and $25,000 during the nine month periods ended June 30, 2017 and 2016, respectively.	35,000	(63,000)	32,000	(37,000)
Other comprehensive income (loss)	42,000	478,000	(592,000)	970,000
Total comprehensive income (loss)	$ 2,173,000	$ 4,344,000	$ (9,381,000)	$ 4,569,000

Consolidated Statements of Com7

Consolidated Statements of Comprehensive Income (Loss) (Unaudited) (Parentheticals) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Unrealized gain (loss) on marketable securities, tax	$ (12,000)	$ (364,000)	$ 404,000	$ (695,000)
Reclassification adjustments for securities, tax (expense) benefit	7,000	13,000	404,000	24,000
Foreign currency translation, tax benefit	$ (23,000)	$ 15,000	$ (21,000)	$ 25,000

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Treasury Stock [Member]	Noncontrolling Interest [Member]	Total
Balance, September 30, 2016, as previously reported (in shares) at Sep. 30, 2015	13,061,673
Balance, September 30, 2016, as previously reported at Sep. 30, 2015	$ 131,000	$ 65,049,000	$ 119,165,000	$ 20,000	$ (1,751,000)	$ 793,000	$ 183,407,000
Stock based compensation expense		567,000					567,000
Net (loss) income			3,599,000				3,599,000
Amount reclassified from other comprehensive (loss) income				(39,000)			(39,000)
Unrealized gain (loss) on marketable securities, net				1,046,000			1,046,000
Purchase of treasury stock					(11,174,000)		(11,174,000)
Foreign currency translation, net				(37,000)			(37,000)
Balance (in shares) at Jun. 30, 2016	13,297,508
Balance at Jun. 30, 2016	$ 133,000	66,582,000	122,764,000	990,000	(12,925,000)		$ 177,544,000
Exercise of options (in shares)	107,531						107,531
Exercise of options	$ 1,000	870,000					$ 871,000
Restricted stock (in shares)	5,000
Purchase of subsidiary shares from non-controlling interest		(903,000)				(793,000)	(1,696,000)
Issuance of restricted stock to purchase subsidiary shares from non-controlling interest (in shares)	123,304
Issuance of restricted stock to purchase subsidiary shares from non-controlling interest	$ 1,000	999,000					1,000,000
Balance, September 30, 2016, as previously reported (in shares) at Sep. 30, 2016	13,336,508
Balance, September 30, 2016, as previously reported at Sep. 30, 2016	$ 133,000	67,034,000	126,738,000	803,000	(12,925,000)		181,783,000
Stock based compensation expense		38,000					38,000
Net (loss) income			(8,789,000)				(8,789,000)
Amount reclassified from other comprehensive (loss) income				(607,000)			(607,000)
Unrealized gain (loss) on marketable securities, net				(17,000)			(17,000)
Purchase of treasury stock					(54,203,000)		(54,203,000)
Foreign currency translation, net				32,000			32,000
Forgiveness of debt		552,000					552,000
Issuance of unrestricted stock (in shares)	61,600
Issuance of unrestricted stock	$ 1,000	403,000					404,000
Balance (in shares) at Jun. 30, 2017	13,398,108
Balance at Jun. 30, 2017	$ 134,000	$ 68,027,000	$ 117,949,000	$ 211,000	$ (67,128,000)		$ 119,193,000
Exercise of options (in shares)							0

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Cash flows from operating activities :
Net (loss) income from continuing operations	$ (7,033,000)	$ 2,195,000
Net income (loss) from discontinued operations, net of income tax	(1,756,000)	1,404,000
Net income (loss)	(8,789,000)	3,599,000
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
Depreciation and amortization	75,000	353,000
Deferred income taxes	1,199,000	(78,000)
Impairment of consumer receivables	148,000	124,000
Stock based compensation	81,000	567,000
Loss on sale of available-for-sale securities	1,011,000	63,000
Unrealized gain on other investments		(246,000)
Unrealized foreign exchange loss on other investments		59,000
Reserve for loss on other investments		1,000,000
Loss on other investments	3,590,000
Forgiveness of debt	552,000
Operating lease adjustment		21,000
Earnings from equity method investment	(2,759,000)	(6,193,000)
Changes in:
Prepaid and income taxes receivable	(6,022,000)	2,512,000
Due from third party collection agencies and attorneys	(320,000)	376,000
Other assets	3,184,000	(2,444,000)
Other liabilities	1,294,000	1,911,000
Net cash used in operating activities of discontinued operations	(3,041,000)	(6,649,000)
Net cash (used in) operating activities	(9,797,000)	(5,025,000)
Cash flows from investing activities:
Purchase of consumer receivables acquired for liquidation	(2,213,000)	(6,936,000)
Principal collected on receivables acquired for liquidation	6,324,000	7,384,000
Purchase of available-for-sale securities	(13,193,000)	(11,704,000)
Proceeds from sale of available-for-sale securities	62,406,000	16,302,000
Purchase of non-controlling interest		(800,000)
Investments in personal injury claims – advances	(3,351,000)
(Increase) decrease in equity method investment	2,808,000	1,826,000
Capital expenditures	(19,000)	(120,000)
Net cash provided by (used in) investing activities of discontinued operations	1,548,000	(6,756,000)
Net cash provided by/(used in) investing activities	54,310,000	(804,000)
Cash flows from financing activities:
Proceeds from exercise of stock options		872,000
Purchase of treasury stock	(54,203,000)	(11,174,000)
Borrowings from line of credit	9,600,000
Net cash provided by financing activities of discontinued operations	9,000,000	11,056,000
Net cash (used in) provided by financing activities	(35,603,000)	754,000
Foreign currency effect on cash	(37,000)
Net increase (decrease) in cash, cash equivalents and restricted cash including cash, cash equivalents classified within assets related to discontinued operations	8,873,000	(5,075,000)
Less: net decrease in cash, cash equivalents and restricted cash classified within assets related to discontinued operations	58,000	(283,000)
Net increase (decrease) in cash, cash equivalents and restricted cash	8,931,000	(5,358,000)
Cash, cash equivalents and restricted cash at beginning of period	16,282,000	19,947,000
Cash, cash equivalents and restricted cash at end of period	25,213,000	14,589,000
Supplemental disclosure of cash flow information:
Interest	3,031,000	2,353,000
Taxes	6,046,000
Restricted Stock [Member]
Supplemental disclosure of non-cash flow investing activities :
Issuance of stock		1,000,000
Issuance of stock		1,000,000
Unrestricted Stock [Member]
Supplemental disclosure of non-cash flow investing activities :
Issuance of stock	404,000
Issuance of stock	$ 404,000

Note 1 - Restatement of Financi

Note 1 - Restatement of Financial Statements	9 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Accounting Changes and Error Corrections [Text Block]	Note 1— Restatement of Financial Statements The following tables summarize the effects of the restatements on the specific items presented in the Company’s consolidated financial statements previously included in the Original Form 10 Consolidated Balance Sheet June 30, 2017 As Reported De-Consolidation of Pegasus (1) Adjustments Restated ASSETS Cash and cash equivalents $ 15,315,000 $ (81,000 ) $ (21,000 ) (2) $ 15,213,000 Restricted cash 34,748,000 (24,748,000 ) — 10,000,000 Available for sale investments (at fair value) 5,500,000 — — 5,500,000 Consumer receivables acquired for liquidation (at net realizable value) 9,118,000 — 92,000 (2) 9,210,000 Investment in personal injury claims, net 27,538,000 (24,187,000 ) — 3,351,000 Due from third party collection agencies and attorneys 1,367,000 — (10,000 ) (2) 1,357,000 Prepaid and income taxes receivable 4,836,000 — 1,900,000 (5)(8) 6,736,000 Furniture and equipment, net 141,000 — — 141,000 Equity method investment — 48,639,000 (106,000 ) (7) 48,533,000 Deferred income taxes 18,940,000 — (4,820,000 ) (2)(8) 14,120,000 Goodwill 1,410,000 — — 1,410,000 Other assets 3,576,000 (109,000 ) (59,000 ) (2) 3,408,000 Assets related to discontinued operations 93,723,000 — (31,000 ) (5)(6) 93,692,000 Total assets $ 216,212,000 $ (486,000 ) $ (3,055,000 ) $ 212,671,000 LIABILITIES Line of credit 9,600,000 — — 9,600,000 Other liabilities 6,079,000 (755,000 ) (75,000 ) (2) 5,249,000 Liabilities related to discontinued operations 78,628,000 — 1,000 (4) 78,629,000 Total liabilities 94,307,000 (755,000 ) (74,000 ) 93,478,000 Commitments and contingencies STOCKHOLDERS’ EQUITY Preferred stock — — — — Common stock 134,000 — — 134,000 Additional paid-in capital 67,467,000 — 560,000 (5)(6) 68,027,000 Retained earnings 122,669,000 — (4,720,000 ) (2)(3)(4)(5)(6)(7)(8) 117,949,000 Accumulated other comprehensive income (loss) (968,000 ) — 1,179,000 (2) 211,000 Treasury stock (at cost) (67,128,000 ) — — (67,128,000 ) Non-controlling interest (269,000 ) 269,000 — — Total stockholders’ equity 121,905,000 269,000 (2,981,000 ) 119,193,000 Total liabilities and stockholders’ equity $ 216,212 ,000 $ (486,000 ) $ (3,055,000 ) $ 212,671,000 Consolidated Statement of Operations For the Three Months Ended June 30, 2017 As Reported De-Consolidation of Pegasus (1) Adjustments Restated Revenues: Finance income, net $ 3,980,000 $ — $ 13,000 (2) $ 3,993,000 Personal injury claims income 5,569,000 (5,328,000 ) — 241,000 Disability fee income 1,134,000 — — 1,134,000 Total revenues 10,683,000 (5,328,000 ) 13,000 5,368,000 Other income 84,000 — 6,000 (2) 90,000 10,767,000 (5,328,000 ) 19,000 5,458,000 General and administrative 7,252,000 (1,679,000 ) 493,000 (2)(6) 6,066,000 Interest 133,000 (2,000 ) 33,000 (2) 164,000 Impairment of consumer receivables 148,000 — — 148,000 Loss (earnings) from equity method investment — (2,917,000 ) 207,000 (7) (2,710,000 ) 7,533,000 (4,598,000 ) 733,000 3,668,000 Income (loss) from continuing operations before income tax 3,234,000 (730,000 ) (714,000 ) 1,790,000 Income tax (benefit)/expense 1,198,000 — (979,000 ) (8) 219,000 Net income (loss) from continuing operations 2,036,000 (730,000 ) 265,000 1,571,000 Income (loss) from discontinued operations, net of income tax 526,000 — 34,000 (3)(5)(8) 560,000 Less: net income attributable to non-controlling interests 730,000 (730,000 ) — — Net income attributable to Asta Funding, Inc. $ 1,832,000 $ — $ 299,000 $ 2,131,000 Net income (loss) per basic shares: Continuing operations $ 0.20 $ 0.24 Discontinued operations 0.08 0.08 $ 0.28 $ 0.32 Net income (loss) per diluted shares: Continuing operations $ 0.19 $ 0.23 Discontinued operations 0.08 0.08 $ 0.27 $ 0.31 Consolidated Statement of Operations For the Nine Months Ended June 30, 2017 As Reported De-Consolidation of Pegasus (1) Adjustments Restated Revenues: Finance income, net $ 11,999,000 $ — $ 19,000 (2) $ 12,018,000 Personal injury claims income 10,017,000 (9,766,000 ) — 251,000 Disability fee income 3,990,000 — — 3,990,000 Total revenues 26,006,000 (9,766,000 ) 19,000 16,259,000 Other income (74,000 ) — (52,000 ) (2) (126,000 ) 25,932,000 (9,766,000 ) (33,000 ) 16,133,000 General and administrative 31,354,000 (6,052,000 ) 309,000 (2)(6) 25,611,000 Interest 169,000 (6,000 ) 34,000 (2) 197,000 Impairment of consumer receivables 148,000 — — 148,000 Loss (earnings) from equity method investment — (2,966,000 ) 207,000 (7) (2,759,000 ) 31,671,000 (9,024,000 ) 550,000 23,197,000 (Loss) income from continuing operations before income tax (5,739,000 ) (742,000 ) (583,000 ) (7,064,000 ) Income tax (benefit)/expense (2,170,000 ) — 2,139,000 (8) (31,000 ) Net loss from continuing operations (3,569,000 ) (742,000 ) (2,722,000 ) (7,033,000 ) Loss from discontinued operations, net of income tax (1,083,000 ) — (673,000 ) (3)(5)(8) (1,756,000 ) Less: net income attributable to non-controlling interests 742,000 (742,000 ) — — Net loss attributable to Asta Funding, Inc. $ (5,394,000 ) $ — $ (3,395,000 ) $ (8,789,000 ) Net income (loss) per basic shares: Continuing operations $ (0.46 ) $ (0.75 ) Discontinued operations (0.11 ) (0.19 ) $ (0.57 ) $ (0.94 ) Net income (loss) per diluted shares: Continuing operations $ (0.46 ) $ (0.75 ) Discontinued operations (0.11 ) (0.19 ) $ (0.57 ) $ (0.94 ) Consolidated Statement of Comprehensive Income For the Three Months Ended June 30, 2017 As Reported De-Consolidation of Pegasus (1) Adjustments Restated Comprehensive income (loss) is as follows: Net income $ 1,832,000 $ — $ 299,000 $ 2,131,000 Net unrealized securities (loss) gain, net of tax 18,000 — — 18,000 Reclassification adjustments for securities sold, net of tax (11,000 ) — — (11,000 ) Foreign currency translation, net of tax (249,000 ) — 284,000 (2) 35,000 Other comprehensive (loss) income (242,000 ) — 284,000 42,000 Total comprehensive income $ 1,590,000 $ — $ 583,000 $ 2,173,000 Consolidated Statement of Comprehensive Loss For the Nine Months Ended June 30, 2017 As Reported De-Consolidation of Pegasus (1) Adjustments Restated Comprehensive (loss) income is as follows: Net loss $ (5,394,000 ) $ — $ (3,395,000 ) $ (8,789,000 ) Net unrealized securities (loss) gain, net of tax (17,000 ) — — (17,000 ) Reclassification adjustments for securities sold, net of tax (607,000 ) — — (607,000 ) Foreign currency translation, net of tax (430,000 ) — 462,000 (2)(6) 32,000 Other comprehensive (loss) income (1,054,000 ) 462,000 (592,000 ) Total comprehensive loss $ (6,448,000 ) $ $ (2,933,000 ) $ (9,381,000 ) Consolidated Statement of Cash Flows For the Nine Months Ended June 30, 2017 As Reported Adjustments Restated Cash flows from operating activities: Net loss from continuing operations $ (4,311,000 ) $ (2,722,000 ) $ (7,033,000 ) Net loss from discontinued operations (1,083,000 ) (673,000 ) (1,756,000 ) Net loss (5,394,000 ) (3,395,000 ) (8,789,000 ) Adjustments to reconcile net loss to net cash (used in) provided by operating activities: Depreciation and Amortization 154,000 (79,000 ) 75,000 Deferred income taxes (2,994,000 ) 4,193,000 (2)(8) 1,199,000 Impairments of consumer receivables acquired for liquidation 148,000 — 148,000 Stock based compensation 81,000 — 81,000 Loss on sale of available-for-sale securities 1,011,000 — 1,011,000 Unrealized gain on other investments 3,590,000 ) — 3,590,000 Earnings from equity method investment — (2,759,000 ) (7) (2,759,000 ) Forgiveness of debt — 552,000 (5) 552,000 Changes in: Prepaid and income taxes receivable (3,956,000 ) (2,066,000 ) (5)(8) (6,022,000 ) Due from third party collection agencies and attorneys (362,000 ) 42,000 (2) (320,000 ) Other assets 3,050,000 ) 134,000 (2) 3,184,000 Income tax payable (252,000 ) 252,000 (6) — Other liabilities 1,083,000 211,000 (2) 1,294,000 Non-controlling interest 742,000 (742,000 ) (1) — Net cash (used in) provided by operating activities of discontinued operations (3,654,000 ) 613,000 (5)(6) (3,041,000 ) Net cash (used in) provided by operating activities (6,753,000 ) (3,044,000 ) (9,797,000 ) Cash flows from investing activities: Purchase of consumer receivables acquired for liquidation (2,213,000 ) — (2,213,000 ) Principal collected on receivables acquired for liquidation 6,618,000 (294,000 ) (2) 6,324,000 Purchase of available-for-sale securities (13,193,000 ) — (13,193,000 ) Proceeds from sales of available-for-sale securities 62,406,000 — 62,406,000 Decrease in equity method investment — 2,808,000 (5)(6) 2,808,000 Investments in personal injury claims — advances (14,624,000 ) 11,273,000 (1) (3,351,000 ) Investments in personal injury claims — receipts 35,375,000 (35,375,000 ) (1) — Capital expenditures (19,000 ) — (19,000 ) Net cash provided by investing activities related to discontinued operations 1,548,000 — 1,548,000 Net cash provided by (used in) investing activities 75,898,000 (21,588,000 ) 54,310,000 Cash flows from financing activities: Purchase of treasury stock (54,203,000 ) — (54,203,000 ) Distributions to non-controlling interest (366,000 ) 366,000 (1) — Borrowings from line of credit 9,600,000 — 9,600,000 Net cash provided by financing activities related to discontinued operations 9,000,000 — 9,000,000 Net cash (used in) provided by financing activities (35,969,000 ) 366,000 (35,603,000 ) Foreign currency effect on cash — (37,000 ) (2) (37,000 ) Net increase in cash, cash equivalents and restricted cash including cash, cash equivalents classified within assets related to discontinued operations 33,176,000 (24,303,000 ) 8,873,000 Less: net decrease in cash, cash equivalents and restricted cash classified within assets related to discontinued operations 58,000 — 58,000 Net increase ( decrease ) in cash , cash equivalents and restricted cash 33,234,000 (24,303,000 ) (1)(2)(4)(5)(6)(7)(8) 8,931,000 Cash, cash equivalents and restricted cash at beginning of period 16,829,000 (547,000 ) 16,282,000 Cash , cash equivalents and restricted cash at end of period $ 50,063,000 $ (24,850,000 ) $ 25,213,000 As previously disclosed in the Current Report on Form 8 January 18, 2018, September 30, 2016, 2015 2014, December 31, 2016, March 31, 2017 June 30, 2017, no On September 17, 2018, 10 10 September 30, 2016, 2015 2014, 10 December 31, 2016 March 31, 2017. No. 1 10 10 June 30, 2017 ( August 9, 2017 ( 10 Prior period amounts have already been restated in the Company's Form 10 not Restatement Background On January 11, 2018, 810 Consolidation 830 Foreign Currency Matters not The “As Reported” amounts in the tables above represent the amounts reported in the Restated Form 10 December 13, 2017 ( 8 20 The following errors were identified as part of the restatement: 1. In connection with the Company determining it lacked the requisite control to consolidate Pegasus during the Non-Reliance Period, the Company has now accounted for its investment in Pegasus under the equity method in accordance with US GAAP. On the Company’s June 30, 2017 $24,829,000; $24,187,000; $109,000; $755,000; $269,000, $48,639,000. On the Company’s consolidated statement of operations, this resulted in (i) a decrease in total revenues of $5,328,000; $1,681,000; $730,000; $2,917,000 three June 30, 2017. no On the Company’s consolidated statement of operations, this resulted in (i) a decrease in total revenues of $9,766,000; $6,058,000; $742,000; $2,966,000 nine June 30, 2017. no 2. The Company determined that it had not 830. The correction to properly apply U.S. GAAP to these foreign currency matters resulted in increased revenue of $13,000, $6,000, $493,000 $34,000 three June 30, 2017. The correction to properly apply U.S. GAAP to these foreign currency matters resulted in increased revenue of $19,000, $52,000, $580,000, $34,000 nine June 30, 2017. The correction of foreign currency transaction on the consolidated balance sheet are as follows: Increase (decrease) in: Impact from September 30, 2016 10K/A filing Current period impact Cumulative net impact Cash and cash equivalents $3,000 $(24,000) $(21,000) Consumer receivables acquired for liquidation (245,000) 337,000 92,000 Due from third party collection agencies and attorneys 45,000 (55,000) (10,000) Deferred income taxes (722,000) (472,000) (1,194,000) Other assets (33,000) (26,000) (59,000) Other liabilities (18,000) (57,000) (75,000) Accumulated other comprehensive loss 718,000 461,000 1,179,000 Retained earnings (1,653,000) (645,000) (2,298,000) 3. Prior to the sale of its structured settlement business, the Company purchased periodic payments under structured settlements and annuity policies from individuals in exchange for a lump sum payment. The Company has elected to carry the structured settlements at fair value in accordance with the guidance of FASB ASC, Recognition and Measurement of Financial Assets and Financial Liabilities (ASC 822 10 50 28 50 22 As previously disclosed in the Restated Form 10 not December 31, 2016 $2.6 $1.0 In connection with the Company’s filing of the Form 10 September 17, 2018, September 30, 2016, $727,000. three December 31, 2016, $727,000 nine June 30, 2017. 4. The Company determined that it had not $648,000 $648,000 September 30, 2016 June 30, 2017. 5. The Company discovered that it did not June 2015 $34,000 $153,000 three nine June 30, 2017. The correction of these errors on the consolidated balance sheet are as follows: Increase (decrease) in: Impact from September 30, 2016 10K/A filing Current period impact Cumulative net impact Assets related to discontinued operations $307,000 $(357,000) $(50,000) Liabilities related to discontinued operations 756,000 (756,000) — Retained earnings (442,000) (155,000) (597,000) Additional paid in capital - 552,000 552,000 6. The Company identified other transactions that had not $0 $271,000 three nine June 30, 2017. The correction of these errors on the consolidated balance sheet are as follows: Increase (decrease) in: Impact from September 30, 2016 10K/A filing Current period impact Cumulative net impact Other liabilities $269,000 $(269,000) $ — Retained earnings (137,000) 270,000 133,000 Assets related to discontinued operations 45,000 - 45,000 Additional paid in capital 8,000 - 8,000 7. The Company identified the personal injury claims asset balance of Pegasus was determined to be overstated at March 31, 2017 $400,000. $0 $320,000 three nine June 30, 2017. $101,000 10 three nine June 30, 2017, $207,000 8. Some of the corrections noted above impacted earnings (loss) before taxes which, in turn, required a calculation of the tax impact. The net impact to the Company’s consolidated balance sheet was an (i) increase to prepaid and income taxes receivable of $1,875,000; $3,627,000. On the Company’s consolidated statement of operations, there was (i) a net (decrease) to income tax expense of ( $979,000 93,000 three June 30, 2017. On the Company’s consolidated statement of operations, there was (i) a net increase to income tax expense of $2,139,000; $233,000 nine June 30, 2017. All of the following notes to consolidated financial statements have been revised to reflect the effects of the above mentioned restatements.

Note 2 - Business and Basis of

Note 2 - Business and Basis of Presentation	9 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]	Note 2—Business Business Asta Funding, Inc., together with its wholly owned significant operating subsidiaries Palisades Collection, LLC, Palisades Acquisition XVI, LLC (“Palisades XVI”), Palisades Acquisition XIX, LLC (“Palisades XIX”), Palisades Acquisition XXIII, LLC (“Palisades XIX”), VATIV Recovery Solutions LLC (“VATIV”), ASFI Pegasus Holdings, LLC (“APH”), EMIRIC, LLC (“EMIRIC”), Fund Pegasus, LLC (“Fund Pegasus”), GAR Disability Advocates, LLC (“GAR Disability Advocates”), Five Star Veterans Disability, LLC (“Five Star”), Simia Capital, LLC (“Simia”) and other subsidiaries, which are not 80% 50% Consumer receivables The Company started out in the consumer receivable business in 1994. Personal injury claims Simia and our equity method investment in Pegasus conducts their business solely in the United States. These companies obtain their business from external brokers and internal sales professionals soliciting individuals with personal injury claims. Business is also obtained from their websites and through attorneys. Social security benefit advocacy GAR Disability Advocates provides its disability advocacy services throughout the United States. It relies upon search engine optimization (“SEO”) to bring awareness to its intended market. Discontinued Operations US GAAP requires the results of operations of a component of an equity that either has been disposed of or is classified as held for sale to be reported as discontinued operations in the consolidated financial statements if the sale or disposition represents a strategic shift that has (or will have) a major effect on an entity’s operations and financial results. On December 13, 2017, 8 Basis of Presentation The consolidated balance sheet as of June 30, 2017, three nine June 30, 2017 2016, three nine June 30, 2017 2016, nine June 30, 2017 2016, nine June 30, 2017 2016, September 30, 2016 10 June 30, 2017, three nine June 30, 2017 2016 nine June 30, 2017 2016 three nine June 30, 2017 2016 not The accompanying unaudited consolidated financial statements have been prepared in accordance with Rule 10 01 X not 10 The consolidated financial statements are prepared in accordance with US GAAP and industry practices. The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates including management’s estimates of future cash flows and the resulting rates of return. Principles of Consolidation The consolidated financial statements include the accounts of Asta Funding, Inc. and its wholly owned and majority owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Concentration of Credit Risk – Cash and Restricted Cash The Company considers all highly liquid investments with a maturity date of three Cash balances are maintained at various depository institutions and are insured by the Federal Deposit Insurance Corporation (“FDIC”). The Company had cash balances with eleven June 30, 2017 $9.8 three $2.2 not $10.0 not 7 $0.5 not Equity method investment Investee companies that are not not 20% 50% not Pegasus is the Company's 50% 50% 80% Serlefin BPO&O Peru S.A.C. (“Serlefin Peru”) is the Company's 49% 51% three 51% Additionally, the Company and Serlefin jointly purchase international consumer debt portfolios under a purchase agreement. The Company and Serlefin purchase the portfolios on a pro-rata basis of 80% 20%, $115,000 $94,000 $0.4 $0.2 three nine June 30, 2017 2016, The carrying value of the investment in Serlefin Peru was $0.2 June 30, 2017 September 30, 2016. June, 2017 $0.1 not When the Company's carrying value in an equity method investee company is reduced to zero, no not not no three nine June 30, 2017 2016. Personal Injury Claim Advances Management assesses the quality of the personal injury claims portfolio through an analysis of the underlying personal injury fundings on a case by case basis. Cases are reviewed through periodic updates with attorneys handling the cases, as well as with third not Goodwill Goodwill represents the excess of the purchase price over the fair value of the net assets acquired in a business combination, and is accounted for under ASC 350. fourth not not two 1 not no 2 2 $1.4 $1.4 Reclassifications Certain prior period amounts in the accompanying consolidated financial statements have been reclassified to conform to the current year presentation. These reclassifications had no Recent Accounting Pronouncements In May 2014, 606, December 15, 2017 December 15, 2016, In January 2016, No. 2016 01, 825 10 December 15, 2017, In February 2016, No. 2016 02 842 December 15, 2018 may In March 2016, No. 2016 09, 718 December 15, 2016, In June 2016, 2016 13, 326 December 15, 2019. In August 2016, 2016 15, 230 eight December 15, 2017. not In November 2016, No. 2016 18, 2016 18" not 2016 18 not 2016 18 October 1, 2016, not In January 2017, 2017 04 350 2 December 15, 2019, not

Note 3 - Available-for-sale Inv

Note 3 - Available-for-sale Investments	9 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Available-for-sale Investments [Text Block]	Note 3—Available Investments classified as available-for-sale at June 30, 2017 September 30, 2016, Amortized Cost Unrealized Gains Unrealized Losses Fair Value June 30, 2017 $ 5,500,000 $ - $ - $ 5,500,000 September 30, 2016 $ 55,724,000 $ 1,088,000 $ (49,000 ) $ 56,763,000 The available-for-sale investments do not six nine June 30, 2017, $1,011,000. $177,000 nine June 30, 2017. nine June 30, 2016, three $63,000 $47,000 $834,000 first nine June 30, 2017 $16,000 nine June 30, 2016. three three June 30, 2017 $18,000. three June 30, 2016, one $32,000. At June 30, 2017, one Unrealized holding gains and losses on available-for-sale securities are included in other comprehensive income (loss) within stockholders’ equity. Realized gains (losses) on available-for-sale securities are included in other income (loss) and, when applicable, are reported as a reclassification adjustment in other comprehensive income (loss).

Note 4 - Consumer Receivables A

Note 4 - Consumer Receivables Acquired for Liquidation	9 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	Note 4—Consumer Accounts acquired for liquidation are stated at their net estimated realizable value and consist primarily of defaulted consumer loans to individuals primarily throughout the United States and South America. The Company may • the interest method; or • the cost recovery method. Prior to October 1, 2013, 310, 310 30, October 1, 2013, Although the Company has switched to the cost recovery method on its current inventory of portfolios, the Company must still analyze a portfolio upon acquisition to ensure which method is appropriate, and once a static pool is established for a quarter, individual receivable accounts are not The Company uses the cost recovery method when collections on a particular pool of accounts cannot be reasonably predicted. Under the cost recovery method, no zero The Company has extensive liquidating experience in the field of distressed credit card receivables, telecommunication receivables, consumer loan receivables, retail installment contracts, consumer receivables, and auto deficiency receivables. The Company aggregates portfolios of receivables acquired sharing specific common characteristics which were acquired within a given quarter. In addition, the Company uses a variety of qualitative and quantitative factors to estimate collections and the timing thereof. The Company obtains and utilizes, as appropriate, input, including but not third The following tables summarize the changes in the balance sheet account of consumer receivables acquired for liquidation during the following periods: For the Three Months Ended June 30, 2017 2016 Balance, beginning of period $ 11,590,000 $ 16,440,000 Acquisitions of receivable portfolio — 751,000 Net cash collections from collection of consumer receivables acquired for liquidation (6,061,000 ) (7,286,000 ) Net cash collections represented by account sales of consumer receivables acquired for liquidation (1,000 ) (83,000 ) Impairment (148,000 ) — Effect of foreign currency translation (163,000 ) 92,000 Finance income recognized 3,993,000 4,571,000 Balance, end of period $ 9,210,000 $ 14,485,000 Finance income as a percentage of collections 65.9 % 62.0 % For the Nine Months Ended June 30, 2017 2016 Balance, beginning of period $ 13,427,000 $ 15,056,000 Acquisitions of receivable portfolio 2,213,000 6,936,000 Net cash collections from collection of consumer receivables acquired for liquidation (18,148,000 ) (22,060,000 ) Net cash collections represented by account sales of consumer receivables acquired for liquidation (191,000 ) (83,000 ) Impairment (148,000 ) (124,000 ) Effect of foreign currency translation 39,000 205,000 Finance income recognized 12,018,000 14,555,000 Balance, end of period $ 9,210,000 $ 14,485,000 Finance income as a percentage of collections 65.5 % 65.7 % During the three nine June 30, 2017, $0.0 $35.0 $0.0 $2.2 three nine June 30, 2016, $2.2 $123.2 $0.3 $6.5 As of June 30, 2017, $4.5 $3.3 $7.8 84.8% $9.2 June 30, 2017. As of June 30, 2016, $4.0 $4.0 $8.0 55.2% $14.5 June 30, 2016. The following table summarizes collections received by the Company’s third three nine June 30, 2017 2016, For the Three Months Ended June 30, For the Nine Months Ended June 30, 2017 2016 2017 2016 Gross collections (1) $ 10,659,000 $ 12,380,000 32,641,000 36,982,000 Commissions and fees (2) 4,597,000 5,011,000 14,302,000 14,839,000 Net collections $ 6,062,000 $ 7,369,000 $ 18,339,000 $ 22,143,000 ( 1 Gross collections include: collections from third ( 2 Commissions are earned by third December 2007 one 3%

Note 5 - Litigation Funding

Note 5 - Litigation Funding	9 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Other Investments Disclosure [Text Block]	Note 5—Litigation Equity Method Investment On December 28, 2011, 80% $5.1 $9.8 $9.8 $14.8 three nine June 30, 2017 2016, $48.5 $48.6 June 30, 2017 September 30, 2016, Equity method investments as of June 30, 2017 September 30, 2016 June 3 0 , 2017 September 30, 2016 Carrying Value Ownership Percentage Carrying Value Ownership Percentage Pegasus Funding, LLC $ 48,533,000 80 % $ 48,582,000 80 % The carrying value of the Company's equity investment at June 30, 2017 $48,533,000, $49,000 $48,582,000. $2,759,000 nine June 30, 2017, $2,808,000 nine June 30, 2017. The carrying value of the Company's equity investment at September 30, 2016 $48,582,000, $7,831,000 $40,751,000. $10,551,000, $2,720,000 2016. On November 8, 2016, 80% 20% not December 28, 2016. December 28, 2011 ( Pursuant to the Term Sheet, the parties thereto have agreed that Pegasus will continue in existence in order to collect advances on its existing Portfolio. The Company will fund overhead expenses relating to the collection of its Portfolio based on a budget agreed upon by the Company and PLF. Any cash received by Pegasus will be distributed to its members in the order provided for in the Operating Agreement. The Company will be repaid an amount equal to 20% October 1, 2016 January 2, 2017, In connection with the Term Sheet, the parties thereto have also entered into a customary mutual release and non-disparagement agreement as well as a release from the non-competition obligations under the Operating Agreement. See Note 20 The results of operations and financial position of the Company’s equity investment in Pegasus are summarized below: Condensed Statement of Operations Information Three months ended June 30 , 201 7 June 30 , 201 6 Personal injury claims income $ 5,068,000 $ 9,838,000 Operating expenses 1,680,000 2,096,000 Income from operations $ 3,388,000 $ 7,742,000 Earnings from equity investment $ 2,710,000 $ 6,193,000 Condensed Statement of Operations Information Nine months ended June 30, 2017 June 30, 2016 Personal injury claims income $ 9,507,000 $ 14,769,000 Operating expenses 6,058,000 4,744,000 Income from operations $ 3,449,000 $ 10,025,000 Company’s equity income from operations $ 2,759,000 $ 8,020,000 Condensed Balance Sheet Information June 30 , 201 7 September 30, 2016 Cash $ 24,829,000 (1) $ 539,000 Investment in personal injury claims 23,927,000 48,289,000 Other assets 109,000 188,000 Total assets $ 48,865,000 $ 49,016,000 Due to Asta $ 31,596,000 $ 34,404,000 Other liabilities 628,000 1,053,000 Equity 16,641,000 13,559,000 Total liabilities and equity $ 48,865,000 $ 49,016,000 ( 1 $24.7 20 Matrimonial Claims (included in Other Assets) On May 8, 2012, 60% 40% 2012, $1.0 twenty-four September 2014, August 2016, $1.5 August 14, 2016, March 31, 2017, September 2014 April 1, 2017, $1.5 second 2017. June 30, 2017, $1.7 no nine June 30, 2017 2016 $0.7 three June 30, 2017.

Note 6 - Furniture & Equipment

Note 6 - Furniture & Equipment	9 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	Note 6—Furniture Furniture and equipment consist of the following as of the dates indicated: June 30, September 30, 2017 2016 Furniture $ 273,000 $ 273,000 Equipment 242,000 235,000 Software 1,363,000 1,350,000 1,878,000 1,858,000 Less accumulated depreciation and amortization 1,737,000 1,662,000 Balance, end of period $ 141,000 $ 196,000

Note 7 - Non Recourse Debt

Note 7 - Non Recourse Debt	9 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Debt Disclosure [Text Block]	Note 7—Non Non-Recourse Debt –Bank of Montreal (“BMO”) In March 2007, $227 July 2007, December 2007, May 2008, February 2009, October 2010 August 2013 ( $300 three August 2013. On August 7, 2013, 100% $15 $15 30% $15 June 3, 2014, $2,901,000 $1,866,000 $16.9 During the month of June 2016, $16.9 June 30, 2017, $164,000, July 10, 2017. Bank Hapoalim B.M. (“Bank Hapoalim”) Line of Credit On May 2, 2014, $20 $20.0 $30 three 275 $150 March 30, 2016, 225 $50 $100 $9.6 June 30, 2017. August 2, 2017 $9.6

Note 8 - Discontinued Operation

Note 8 - Discontinued Operations	9 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]	Note 8—Discontinued On December 31, 2013, 80% $5.9 On December 31, 2015, 20% $1,800,000, $1,000,000 $800,000 two 61,652 $7.95 $400,000 123,304 one December 31, 2016 ( 13 On January 1, 2016, two two one two December 2016. not January 1, 2017. On December 13, 2017, $10.5 $4.49 $5.75 7% first $1.9 September 30, 2017. As a result of this sale all prior periods presented in the Company's consolidated financial statements will account for CBC as a discontinued operation. This determination resulted in the reclassification of the assets and liabilities comprising the structured settlement business to assets related to discontinued operations in the consolidated balance sheets, and a corresponding adjustment to our consolidated statements of operations to reflect discontinued operations for all periods presented. As of June 30, 2017, $93.8 $78.6 September 30, 2016, $91.6 $69.2 three nine June 30, 2017 2016, $0.6 $0.6 $1.8 $1.4 The following table presents the operating results, for the three nine June 30, 2017 2016, Three months ended June 30, 2017 June 30, 2016 Revenues: Unrealized gain on structured settlements $ 7,531,000 $ 1,422,000 Interest income on structured settlements 1,923,000 1,765,000 Loss on sale of structured settlements (5,353,000 ) — Total revenues 4,101,000 3,187,000 Other income 14,000 46,000 4,115,000 3,233,000 Expenses: General and administrative expenses 2,156,000 1,406,000 Interest expense 990,000 833,000 3,146,000 2,239,000 Income from discontinued operations before income tax 969,000 994,000 Income tax expense from discontinued operations 409,000 417,000 Income from discontinued operations, net of income tax $ 560,000 $ 577,000 Nine months ended June 30, 2017 June 30, 2016 Revenues: Unrealized gain on structured settlements $ 4,511,000 $ 4,586,000 Interest income on structured settlements 5,765,000,000 4,473,000 Loss on sale of structured settlements (5,353,000 ) — Total revenues 4,923,000 9,059,000 Other income 44,000 46,000 4,967,000 9,105,000 Expenses: General and administrative expenses 5,152,000 4,157,000 Interest expense 2,871,000 2,349,000 8,023,000 6,506,000 (Loss) income from discontinued operations before income tax (3,056,000 ) 2,599,000 Income tax (benefit) expense from discontinued operations (1,300,000 ) 1,091,000 (Loss) income from discontinued operations before non-controlling interest (1,756,000 ) 1,508,000 Non-controlling interest — 104,000 (Loss) income from discontinued operations, net of income tax $ (1,756,000 ) $ 1,404,000 CBC purchased structured settlement and annuity policies through privately negotiated direct consumer purchases and brokered transactions across the United States. CBC funds the purchases primarily from cash, its revolving line of credit, and its securitized debt, issued through its Blue Bell Receivables (“BBR”) subsidiaries. The major components of assets and liabilities related to discontinued operations are summarized below : June 30, 2017 September 30, 2016 Cash and cash equivalents $ 1,256,000 (1) $ 1,198,000 Restricted cash 499,000 499,000 Structured settlements 88,268,000 86,091,000 Furniture and equipment, net 37,000 47,000 Goodwill 1,405,000 1,405,000 Other assets 2,227,000 2,266,000 Total assets related to discontinued operations $ 93,692,000 $ 91,506,000 Other debt - CBC 76,435,000 67,435,000 Other liabilities 2,194,000 1,803,000 Total liabilities related to discontinued operations $ 78,629,000 $ 69,238,000 ( 1 one June 30, 2017 $0.8 Structured Settlements Prior to the sale of CBC, CBC purchased periodic payments under structured settlements and annuity policies from individuals in exchange for a lump sum payment. The Company elected to carry the structured settlements at fair value. Unearned income on structured settlements is recognized as interest income using the effective interest method over the life of the related structured settlement. Changes in fair value are recorded in unrealized gain (loss) on structured settlements in the Company’s statements of operations. Unrealized gains on structured settlements is comprised of both unrealized gains resulting from fair market valuation at the date of acquisition of the structured settlements and the subsequent fair value adjustments resulting from the change in the discount rate. Of the $4.5 nine June 30, 2017, $5.9 one $0.1 $1.5 no On April 28, 2017, third $7.7 $5.4 three nine June 30, 2017. We elected the fair value treatment under ASC 825 10 50 28 50 32 The purchased personal injury structured settlements result in payments over time through an annuity policy. Most of the annuities acquired involve guaranteed payments with specific defined ending dates. CBC also purchases a small number of life contingent annuity payments with specific ending dates but the actual payments to be received could be less due to the mortality risk associated with the measuring life. CBC records a provision for loss each period. The life contingent annuities are not June 30, 2017. Structured settlements consist of the following as of June 30, 2017 September 30, 2016: June 30, 2017 September 30, 2016 Maturity (1) (2) $ 135,132,000 $ 133,059,000 Unearned income (46,864,000 ) (46,968,000 ) Structured settlements, net $ 88,268,000 $ 86,091,000 ( 1 The maturity value represents the aggregate unpaid principal balance at June 30, 2017 September 30, 2016. ( 2 There are no June 30, 2017 September 30, 2016. Encumbrances on structured settlements as of June 30, 2017 September 30, 2016 Interest Rate June 30, 2017 September 30, 2016 Notes payable secured by settlement receivables with principal and interest outstanding payable until June 2025 (3) 8.75 % $ 1,716,000 $ 1,862,000 Notes payable secured by settlement receivables with principal and interest outstanding payable until August 2026 (3) 7.25 % 3,947,000 4,242,000 Notes payable secured by settlement receivables with principal and interest outstanding payable until April 2032 (3) 7.125 % 3,907,000 3,987,000 Notes payable secured by settlement receivables with principal and interest outstanding payable until February 2037 (3) 5.39 % 17,765,000 18,978,000 Notes payable secured by settlement receivables with principal and interest outstanding payable until March 2034 (3) 5.07 % 13,780,000 14,507,000 Notes payable secured by settlement receivables with principal and interest outstanding payable until February 2043 (3) 4.85 % 13,259,000 13,705,000 Notes payable secured by settlement receivables with principal and interest outstanding payable until January 2069 (3) 5.0 % 17,761,000 — $25,000,000 revolving line of credit (3) 4.1 % 4,300,000 10,154,000 Encumbered structured settlements 76,435,000 67,435,000 Structured settlements not encumbered 11,833,000 18,656,000 Total structured settlements $ 88,268,000 $ 86,091,000 At June 30, 2017, September 30, 2017 (3 months) $ 2,679,000 September 30, 2018 9,020,000 September 30, 2019 9,312,000 September 30, 2020 8,989,000 September 30, 2021 9,474,000 Thereafter 95,658,000 Total $ 135,132,000 The Company assumed $25.9 December 31, 2013, $12.5 5.5%. March 27, 2014 September 29, 2014, three $22.0 4.75%. March 11, 2015, March 1, 2015, February 28, 2015 March 1, 2017. $22.0 $25.0 4.75% 4.1%. March 2017, April 28, 2017. April 28, 2017, June 30, 2017. July 27, 2017 June 30, 2019. On November 26, 2014, fourth $21.8 5.4%. September 25, 2015, fifth $16.6 5.1%. July 8, 2016, $14.8 4.85%. April 7, 2017, seventh $18.3 5.0%. As of June 30, 2017, $76.4 $4.3 $72.1 100%

Note 9 - Commitments and Contin

Note 9 - Commitments and Contingencies	9 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	Note 9 —Commitments and Contingencies Employment Agreement The employment contracts of the original two December 2016. not January 1, 2017. On November 11, 2016, $250,000, 15% 18%. third 15% five may may two two Leases The Company leases its facilities in Englewood Cliffs, NJ, Houston, TX, New York, NY and Conshohocken, PA. Legal Matters In June 2015, one third The Company filed a motion to strike the class action allegations and compel arbitration or, to the extent the court declines to order arbitration, to dismiss the RICO claims. On or about March 31, 2015, July 2015, $13,000 $39,000. July 24, 2015. third not The plaintiffs’ attorneys advised that they were contemplating the filing of another putative class action complaint against the Company alleging substantially the same claims as those that were asserted in this matter. In anticipation of such an eventuality, the Company agreed to non-binding mediation in order to reach a global settlement with other putative class members, which would avert the possibility of further individual or class actions with respect to the affected accounts. To date, the parties have attended two $3.9 $2.0 three March 31, 2016, The Company reassessed the situation at September 30, 2016 $0.3 three September 30, 2016. June 30, 2017 $2.3 20 The Company is a defendant in a lawsuit filed in Montana state court alleging fraud and abuse of process arising from the Company’s business relationship with an entity that finances divorce litigation proceedings. As of June 30, 2017, 20 The Company filed a lawsuit in Delaware state court against a third third third third In the ordinary course of our business, we are involved in numerous legal proceedings. We regularly initiate collection lawsuits, using our network of third not not

Note 10 - Income Recognition, I

Note 10 - Income Recognition, Impairments, and Commissions and Fees	9 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Income Recognition, Impairments, and Commissions and Fees [Text Block]	Note 1 0 —Income Recognition, Impairments, and Commissions and Fees Income Recognition The Company accounts for certain of its investments in finance receivables using the guidance of FASB Accounting Standards Codification (“ASC”), Receivables — Loans and Debt Securities Acquired with Deteriorated Credit Quality (“ASC 310” 310, Under the guidance of ASC 310 30, not The Company uses the cost recovery method when collections on a particular pool of accounts cannot be reasonably predicted. Under the cost recovery method, no zero The Company accounts for its investments in personal injury claims at an agreed upon interest rate, in anticipation of a future settlement. The interest purchased by Pegasus in each claim consists of the right to receive from such claimant part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or award with respect to such claimant’s claim. Management assesses the quality of the personal injury claims portfolio through an analysis of the underlying personal injury fundings on a case by case basis. Cases are reviewed through periodic updates with attorneys handling the cases, as well as with third not The funding of matrimonial actions is on a non-recourse basis. Revenue from matrimonial actions is recognized under the cost recovery method. The Company recognizes revenue for GAR Disability Advocates and Five Star Veterans when disability claimants cases close with the social security administration and the applicable fees are collected. Impairments The Company accounts for its impairments in accordance with ASC 310, 310 310 not In October 2014, $5.0 14% June December December 2015, no not During the fiscal year 2016, $1.0 2017, $3.4 March 31, 2017. Commissions and fees Commissions and fees are the contractual commissions earned by third third

Note 11 - Income Taxes

Note 11 - Income Taxes	9 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Income Tax Disclosure [Text Block]	Note 1 1 —Income Taxes At the end of each interim reporting period, the Company estimates its effective income tax rate expected to be applicable for the full year. The estimate is used in providing for income taxes on a year-to-date basis and may three nine June 30, 2017 12.2% 0.4%, 34.8% 33.7% 2017 35% 2016 35% The Company files income tax returns in the U.S federal jurisdiction, various state jurisdictions, and various foreign countries. The tax returns for the 2014 2015 not

Note 12 - Net Income (Loss) Per

Note 12 - Net Income (Loss) Per Share	9 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Earnings Per Share [Text Block]	Note 1 2 —Net Income (Loss) per Share Basic per share data is calculated by dividing net income (loss) by the weighted average shares outstanding during the period. Diluted earnings per share is calculated similarly, except that it includes the dilutive effect of the assumed exercise of securities, including the effect of shares issuable under the Company’s stock based compensation plans. With respect to the assumed proceeds from the exercise of dilutive options, the treasury stock method is calculated using the average market price for the period. The following table presents the computation of basic and diluted per share data for the three June 30, 2017 2016 Three Months Ended June 30, 2017 Three Months Ended June 30, 2016 Net Income Weighted Average Shares Per Share Amount Net Income Weighted Average Shares Per Share Amount Net (loss) income from continuing operations $ 1,571,000 6,577,784 $ 0.24 $ 3,289,000 11,897,139 $ 0.27 Net (loss) income from discontinued operations 560,000 6,577,784 0.08 577,000 11,897,139 0.05 $ 2,131,000 $ 0.32 $ 3,866,000 $ 0.32 Effect of Dilutive Stock 301,298 (0.01 ) 536,285 (0.01 ) Diluted $ 2,131,000 6,879,082 $ 0.31 $ 3,866,000 12,433,424 $ 0.31 The following table presents the computation of basic and diluted per share data for the nine June 30, 2017 2016 Nine Months Ended June, 2017 Nine Months Ended June 30, 2016 Net Loss Weighted Average Shares Per Share Amount Net Income Weighted Average Shares Per Share Amount Net (loss) income from continuing operations $ (7,033,000 ) 9,389,864 $ (0.75 ) $ 2,195,000 12,023,156 $ 0.18 Net (loss) income from discontinued operations (1,756,000 ) 9,389,864 (0.19 ) 1,404,000 12,023,156 0.12 $ (8,789,000 ) (0.94 ) 3,599,000 $ 0.30 Effect of Dilutive Stock — — 270,917 (0.01 ) Diluted $ (8,789,000 ) 9,389,864 $ (0.94 ) $ 3,599,000 12,294,073 $ 0.29 For the three June 30, 2017, 942,067 $8.15 not For the three June 30, 2016, 56,007 $12.55 not For the nine June 30, 2016, 186,082 $10.88 not

Note 13 - Stock Based Compensat

Note 13 - Stock Based Compensation	9 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	Note 13 —Stock Based Compensation The Company accounts for stock-based employee compensation under ASC 718, 718” 718 On December 16, 2015, 67,100 9,100 58,000 three one Risk-free interest rate 0.24 % Expected term (years) 6.25 Expected volatility 23.4 % Dividend yield 0.00 % On December 16, 2015, 5,000 March 2016. December 31, 2015, 123,304 two 8 one December 31, 2016. On June 8, 2017, 56,600 10,000 10,000 January 1, 2018, 10,000 January 1, 2019 26,600 three one Risk-free interest rate 1.86 % Expected term (years) 5.97 Expected volatility 26.27 % Forfeiture rate 3.49 % Dividend yield 0.00 %

Note 14 - Stock Option Plans

Note 14 - Stock Option Plans	9 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Stock Option Plans [Text Block]	Note 14 —Stock Option Plans 2012 On February 7, 2012, 2012 “2012 March 21, 2012. 2012 The 2012 The Company authorized 2,000,000 2012 2012 540,800 245,625 67,868 1,281,443 June 30, 2017. June 30, 2017, 88 2012 Equity Compensation Plan On December 1, 2005, March 1, 2006. 2002 In addition to permitting the grant of stock options as are permitted under the 2002 The Company authorized 1,000,000 March 21, 2012, no may 2002 On March 5, 2002, 2002 “2002 May 1, 2002. 2002 The 2002 422 1986, not The Company authorized 1,000,000 2002 March 5, 2012, no Summary of the Plans Compensation expense for stock options and restricted stock is recognized over the vesting period. Compensation expense for restricted stock is based upon the market price of the shares underlying the awards on the grant date. The following table summarizes stock option transactions under the 2012 2002 Nine Months Ended June 30, 2017 2016 Number Of Shares Weighted Average Exercise Price Number of Shares Weighted Average Exercise Price Outstanding options at the beginning of period 949,667 $ 8.47 1,043,566 $ 8.47 Options granted 56,600 6.55 67,100 7.93 Options exercised — — (107,531 ) 8.11 Options forfeited/cancelled (53,800 ) 14.01 (8,300 ) 8.14 Outstanding options at the end of period 952,467 $ 8.05 994,835 $ 8.47 Exercisable options at the end of period 867,195 $ 8.13 874,826 $ 8.51 Three Months Ended June 30, 2017 2016 Number Of Shares Weighted Average Exercise Price Number of Shares Weighted Average Exercise Price Outstanding options at the beginning of period 896,867 $ 8.14 1,094,867 $ 8.45 Options granted 56,600 6.55 — — Options exercised — — (100,032 ) 8.24 Options forfeited/cancelled (1,000 ) 7.93 — — Outstanding options at the end of period 952,467 $ 8.05 994,835 $ 8.47 Exercisable options at the end of period 867,195 $ 8.13 874,826 $ 8.51 The following table summarizes information about the 2012 2002 June 30, 2017: Options Outstanding Options Exercisable Range of Exercise Price Number of Shares Outstanding Weighted Remaining Contractual Life (in Years) Weighted Average Exercise Price Number of Shares Exercisable Weighted Average Exercise Price $2.8751 – $4.3000 3,800 1.8 2.95 3,800 $ 2.95 $5.7501 – $8.6250 824,167 5.1 7.86 738,895 7.94 $8.6251 – $11.5000 124,500 5.6 9.40 124,500 9.40 952,467 5.1 8.05 867,195 $ 8.13 The Company recognized $38,000 $30,000 nine three June 30, 2017, $453,000 $126,000 nine three June 30, 2016, June 30, 2017, $132,000 2.0 The intrinsic value of the outstanding and exercisable options as of June 30, 2017 $287,000 $208,000, 4.7 no nine three June 30, 2017. nine three June 30, 2017 $734,000 $81,000, nine three June 30, 2016 $1,368,000 $120,000, nine three June 30, 2017 $371,000 nine three June 30, 2016 $709,000 $0, The following table summarizes information about restricted stock transactions: Nine Months Ended June 30, 2017 2016 Number of Shares Weighted Average Grant Date Fair Value Number of Shares Weighted Average Grant Date Fair Value Unvested at the beginning of period — $ — 44,107 $ 9.28 Awards granted — — 128,304 7.89 Vested — — (39,107 ) 9.57 Forfeited — — — — Unvested at the end of period — $ — 133,304 $ 7.92 Three Months Ended June 30, 2017 2016 Number of Shares Weighted Average Grant Date Fair Value Number of Shares Weighted Average Grant Date Fair Value Unvested at the beginning of period — $ — 138,304 $ 7.92 Awards granted — — — — Vested — — (5,000 ) — Forfeited — — — Unvested at the end of period — $ — 133,304 $ 7.92 The Company did not nine three June 30, 2017, $114,000 $13,000 nine three June 30, 2016, June 30, 2017, no 5,000 first nine 2016, nine June 30, 2017 2016 $0 $326,000 The Company recognized an aggregate total of $38,000 $30,000 nine three June 30, 2017, $567,000 $139,000 nine three June 30, 2016, June 30, 2017, $132,000

Note 15 - Stockholders' Equity

Note 15 - Stockholders' Equity	9 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	Note 15 —Stockholders’ Equity Dividends are declared at the discretion of the Board and depend upon the Company’s financial condition, operating results, capital requirements and other factors that the Board deems relevant. In addition, agreements with the Company’s lenders may, June 30, 2017, no No three nine June 30, 2017 2016. On August 11, 2015, $15,000,000 10b 18 10b5 1 December 31, 2015. December 17, 2015 March 31, 2016 $15 March 17, 2016, $9.9 December 31, 2016 $15 March 22, 2016, no September 30, 2016, 1,186,000 $10.1 On May 25, 2016, 4, 1 2 3 Pursuant to the Agreement, the Company made available to Mangrove and its representatives certain confidential information relating to the Company or its subsidiaries, and Mangrove agreed to make available to the Company and its representatives certain confidential information relating to Mangrove and its affiliates (collectively, the “Confidential Information”). The Company and Mangrove agreed not not one not Further, under the terms of the Agreement, Mangrove and the Company had agreed to certain restrictions during the Discussion Period, which began on May 25, 2016 not third not 220 not On November 21, 2016, 1 2 3 30 one 14A 1934, January 6, 2017. ASTA FUNDING, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (Restated) Note 15—Stockholders’ continued ) On January 6, 2017, The Settlement Agreement provided that, within ten 5,314,009 $10.35 no February 28, 2017. 4,005,701 not January 6, 2017 eleven $10.35 The Settlement Agreement includes customary standstill and related provisions. Mangrove and the Company also agreed on a mutual release of claims. Additionally, the Company indemnified Mangrove from and against any excise tax imposed as a result of this Settlement Agreement. The Settlement Agreement was terminable by either the Company or Mangrove by written notice at any time after the close of business on the second not February 28, 2017 In connection with the Settlement Agreement, the Company also entered into a Voting Agreement dated January 6, 2017 ( not 49% not On January 19, 2017, 5,314,009 $10.35 January 6, 2017, 4,005,701 If more than 5,314,009 not The tender offer expired on February 15, 2017, 11:59 6,022,253 not 708,244 88.24% not 5,314,009 not 44.7% February 6, 2017. second $54.2 $797,000 January 18, 2017 $10.20 2012 471,086 March 10, 2017 $4.9 As of December 31, 2016 three December 31, 2015 2016, February 14, 2017, February 15, 2017, no ASTA FUNDING, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (Restated) Note 15—Stockholders’ continued ) Stockholder Rights Agreement On May 5, 2017, one May 15, 2017. one one $28.60, The Rights generally become exercisable on the earlier of (i) ten 10% ten The exercise price payable and the number of shares of Preferred Stock or other securities or property issuable, upon exercise of the Rights are subject to adjustment from time to time to prevent dilution. In the event that, after a person or a group has become an Acquiring Person, the Company is acquired in a merger or other business combination transaction (or 50% two may $0.01 may one Unless terminated on an earlier date pursuant to the terms of the Rights Agreement, the Rights will expire on June 1, 2018, may June 1, 2018.

Note 16 - Fair Value of Financi

Note 16 - Fair Value of Financial Measurements and Disclosures	9 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Fair Value Disclosures [Text Block]	Note 1 6 —Fair Value of Financial Measurements and Disclosures Fair Value Hierarchy The Company recorded its available-for-sale investments at estimated fair value on a recurring basis. The accompanying consolidated financial statements include estimated fair value information regarding its available-for-sale investments as of June 30, 2017, 820, 820” 820 820 Level 1 Level 2 1 not Level 3 no Disclosures about Fair Value of Financial Instruments FASB ASC 825, 825” not The estimated fair value of the Company’s financial instruments is summarized as follows: June 30, 2017 September 30, 2016 Carrying Amount Fair Value Carrying Amount Fair Value Financial assets Cash equivalents (Level 1) $ 2,864,000 $ 2,864,000 $ 923,000 $ 923,000 Available-for-sale investments (Level 1) 5,500,000 5,500,000 56,764,000 56,764,000 Other investments, net (Level 1) — — 3,590,000 3,590,000 Consumer receivables acquired for liquidation (Level 3) 9,210,000 41,488,000 13,427,000 47,233,000 The following assets have been reclassified to discontinued operations as of June 30, 2017 September 30, 2016: June 30, 2017 September 30, 2016 Carrying Fair Carrying Fair Financial asset Structured settlements (Level 3) 88,268,000 88,268,000 86,091,000 86,091,000 Disclosure of the estimated fair values of financial instruments often requires the use of estimates. The Company uses the following methods and assumptions to estimate the fair value of financial instruments: Cash equivalents – The Company considers all highly liquid debt instruments purchased with an original maturity of three Available-for-sale investments – The available-for-sale securities consist of mutual funds that are valued based on quoted prices in active markets. Other investments – The Company estimated the fair value using the net asset value per share of the investment. There are no 5 October 2014). Consumer receivables acquired for liquidation – The Company computed the fair value of the consumer receivables acquired for liquidation using its proprietary forecasting model. The Company’s forecasting model utilizes a discounted cash flow analysis. The Company’s cash flows are an estimate of collections for consumer receivables based on variables fully described in Note 4 Structured settlements – The Company determined the fair value based on the discounted forecasted future collections of the structured settlements. Unrealized gains (losses) on structured settlements is comprised of both unrealized gains resulting from fair market valuation at the date of acquisition of the structured settlements and the subsequent fair value adjustments resulting from the change in the discount rate. A significant unobservable input used in the fair value measurement of structured settlements is the discount rate. Significant increases and decreases in the discount rate used to estimate the fair value of structured settlements could decrease or increase the fair value measurement of the structured settlements. The discount rate could be affected by factors, which include, but are not 10 The Company’s available-for-sale investments are classified as Level 1 not 1 nine June 30, 2017. no 2 3 first nine 2017. The following table sets forth the Company’s quantitative information about its Level 3 June 30, 2017 ( Fair Value Valuation Technique Significant Unobservable Input Weighted Average Rate Structured settlements at fair value $ 88,268,000 Discounted cash flow Discount rate 4.71% – 6.05% A significant unobservable input used in the fair value measurement of the Company's structured settlements measured at fair value using unobservable inputs (Level 3 The changes in financial instruments at fair value using significant unobservable inputs (Level 3 nine June 30, 2017 Structured Settlement Balance at September 30, 2016 $ 86,091,000 Fair value adjustment (433,000 ) Total gains and losses included in earnings (842,000 ) Changes in allowance 242,000 Purchases 13,363,000 Sales (7,727,000 ) Interest accreted 4,760,000 Payments received (7,186,000 ) Total $ 88,268,000 Realized and unrealized gains and losses on structured settlements included in earnings in the accompanying consolidated statements of operations for the nine June 30, 2017 The amount of total gains for the nine months period included in earnings attributable to the change in unrealized gains relating to assets held at June 30, 2017 $ 4,511,000 Realized loss relating to assets sold during the nine months ended June 30, 2017 $ (5,353,000 ) Total losses included in the nine months ended June 30, 2017 $ (842,000 )

Note 17 - Segment Reporting

Note 17 - Segment Reporting	9 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	Note 17 —Segment Reporting The Company operates through strategic business units that are aggregated into three three • Consumer receivables - may may • Personal injury claims (Equity Method of Investment) January 2017, not three nine June 30, 2017 • Social Security benefit advocacy – Certain non-allocated administrative costs, interest income, interest expense and various other non-operating income and expenses are reflected in Corporate. Corporate assets include cash and cash equivalents, restricted cash, available-for-sale securities, property and equipment, goodwill, deferred taxes, other assets, and assets related to discontinued operations. The following table shows results by reporting segment for the three nine June 30, 2017 2016. (Dollars in millions) Consumer GAR Disability Personal Injury Claims Including Equity Investment (2) Corporate (3) Total Three Months Ended June 30, 2017: Revenues $ 4.0 $ 1.1 $ 0.3 $ — $ 5.4.4 Other income — — — — 0.1 Segment profit (loss) 2.9 0.0 2.6 (3.7 ) 1.8 2016: Revenues 4.6 1.2 — — 5.8 Other income — — — 0.2 0.2 Segment profit (loss) 4.2 (1.8 ) 6.2 (3.6 ) 5.0 Nine Months Ended June 30, 2017: Revenues $ 12.0 $ 4.0 $ 0.3 $ — $ 16.3.4 Other income — — — (0.1 ) (0.1 ) Segment profit (loss) 9.7 (1.4 ) 2.3 (17.7 ) (7.1 ) Segment Assets(1) 19.6 3.3 52.9 136.9 (4) 212.7 2016: Revenues 14.6 2.7 — — 17.3 Other income — — — 1.2 1.2 Segment profit (loss) 10.7 (6.3 ) 8.0 (9.1 ) 3.3 Segment Assets(1) 19.2 1.5 45.1 180.8 (4) 246.6 The Company does not ( 1 Includes other amounts in other line items on the consolidated balance sheet. ( 2 The Company records Pegasus as an equity investment in its consolidated financial statements. For segment reporting the Company has included its pro-rated share of the earnings and losses from its investment under the Personal Injury Claims segment. ( 3 Corporate is not three not ( 4 Included in Corporate are approximately $93.7 $84.8 June 30, 2017 2016,

Note 18 - Accumulated Other Com

Note 18 - Accumulated Other Comprehensive (Loss) Income	9 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Comprehensive Income (Loss) Note [Text Block]	Note 18 —Accumulated Other Comprehensive (Loss) Income Accumulated other comprehensive (loss) income consists of: Nine Months Ended June 30, 2017 Year Ended September 30, 2016 Unrealized Gain (loss) on marketable securities Foreign currency translation, net Total Unrealized Gain (loss) on marketable securities Foreign currency translation, net Total Beginning Balance $ 624,000 $ 179,000 $ 803,000 $ (205,000 ) $ 225,000 $ 20,000 Change in unrealized (losses) gains on foreign currency translation, net of tax benefit/(expense) of ($21,000) and $31,000 at June 30 2017, and September 30, 2016, respectively. — 32,000 32,000 — (46,000 ) (46,000 ) Change in unrealized (losses) gains on marketable securities, net of tax benefit/ (expense) of $404,000 and ($529,000) at June 30 2017, and September 30, 2016, respectively. (607,000 ) — (607,000 ) 868,000 — 868,000 Amount reclassified from accumulated other comprehensive loss, net of tax benefit of $11,000 and $24,000 at June 30 2017, and September 30, 2016, respectively. (17,000 ) — (17,000 ) (39,000 ) — (39,000 ) Net current-period other comprehensive (loss) income (624,000 ) 32,000 (592,000 ) 829,000 (46,000 ) $ 783,000 Ending balance $ — $ 211,000 $ 211,000 $ 624,000 $ 179,000 $ 803,000 Nine Months Ended June 30, 2016 Unrealized Gain (loss) on marketable securities Foreign currency translation, net Total Beginning Balance $ (205,000 ) $ 225,000 $ 20,000 Change in unrealized (losses) gains on foreign currency translation, net of tax benefit/(expense) of $25,000 during the nine month period ended June 30, 2016. - (37,000 ) (37,000 ) Change in unrealized (losses) gains on marketable securities, net of tax benefit/ (expense) of ($695,000) during the nine month period ended June 30, 2016. 1,046,000 - 1,046,000 Amount reclassified from accumulated other comprehensive loss, net of tax benefit of $24,000 during the nine month period ended June 30, 2016. (39,000 ) - (39,000 ) Net current-period other comprehensive (loss) income 1,007,000 (37,000 ) 970,000 Ending balance $ 802,000 $ 188,000 $ 990,000

Note 19 - Related Party Transac

Note 19 - Related Party Transactions	9 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	Note 19 —Related Party Transactions On September 17, 2015, not two September 17, 2017. three nine June 30, 2017 2016, $20,000 $60,000, no June 30, 2017 September 30, 2016. In addition, A. L. Piccolo & Co., Inc. (“ALP”), which is also owned by Louis Piccolo, received a fee from Pegasus which was calculated based on amounts loaned to Pegasus by Fund Pegasus up to maximum of $700,000. six 4% December 28, 2016. three nine June 30, 2017 2016, $33,000 $100,000, In June 2015, $0.5 $1.2 January 2017, For the three nine June 30, 2017, $49,000 $0.2 three nine June 30, 2016, $32,000 $0.2 June 30, 2017 September 30, 2016, $0.0 $0.8 In June 2017, $0.6 55,000 $0.4 three nine June 30, 2017, not

Note 20 - Subsequent Events

Note 20 - Subsequent Events	9 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Subsequent Events [Text Block]	Note 20—Subsequent Simia Effective November 11, 2016, five may may two 5 As of July 17, 2017, no No Pegasus The Company filed for arbitration with the American Arbitration Association ("AAA") against Pegasus in April 2017 April 18, 2017, June 30, 2017 $24.7 5 On July 17, 2017, August 25, 2017 On January 12, 2018, Additionally, on January 12, 2018, 20% $1,800,000. 100% As a result of the purchase of the Seller’s 20% January 12, 2018 March 31, 2018, 5 Legal Matters A competitor of the Company's former subsidiary CBC alleged that CBC had unlawfully purchased certain of the competitor's trade secrets and customer lists from intermediaries who allegedly arranged and/or paid for said materials from the competitor. CBC denied any wrongdoing and disclaimed liability. The parties settled the matter for a payment by the Company of $0.5 November 22, 2017, On November 24, 2017, $0.8 9 On January 23, 2018, $2.3 one third $4.6 third 9 Special Dividend On February 5, 2018, $5.30 February 28, 2018 February 16, 2018, March 1, 2018. $35 IRS Examination The Company's amended federal tax return for the years ended September 30, 2014 2015 US Tax Reform On December 22, 2017 35% 21%. September 30, 2017, one not first 2018.

Significant Accounting Policies

Significant Accounting Policies (Policies)	9 Months Ended
	Jun. 30, 2017
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The consolidated balance sheet as of June 30, 2017, three nine June 30, 2017 2016, three nine June 30, 2017 2016, nine June 30, 2017 2016, nine June 30, 2017 2016, September 30, 2016 10 June 30, 2017, three nine June 30, 2017 2016 nine June 30, 2017 2016 three nine June 30, 2017 2016 not The accompanying unaudited consolidated financial statements have been prepared in accordance with Rule 10 01 X not 10 The consolidated financial statements are prepared in accordance with US GAAP and industry practices. The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates including management’s estimates of future cash flows and the resulting rates of return.
Consolidation, Policy [Policy Text Block]	Principles of Consolidation The consolidated financial statements include the accounts of Asta Funding, Inc. and its wholly owned and majority owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Concentration of Credit Risk – Cash and Restricted Cash The Company considers all highly liquid investments with a maturity date of three Cash balances are maintained at various depository institutions and are insured by the Federal Deposit Insurance Corporation (“FDIC”). The Company had cash balances with eleven June 30, 2017 $9.8 three $2.2 not $10.0 not 7 $0.5 not
Equity Method Investments [Policy Text Block]	Equity method investment Investee companies that are not not 20% 50% not Pegasus is the Company's 50% 50% 80% Serlefin BPO&O Peru S.A.C. (“Serlefin Peru”) is the Company's 49% 51% three 51% Additionally, the Company and Serlefin jointly purchase international consumer debt portfolios under a purchase agreement. The Company and Serlefin purchase the portfolios on a pro-rata basis of 80% 20%, $115,000 $94,000 $0.4 $0.2 three nine June 30, 2017 2016, The carrying value of the investment in Serlefin Peru was $0.2 June 30, 2017 September 30, 2016. June, 2017 $0.1 not When the Company's carrying value in an equity method investee company is reduced to zero, no not not no three nine June 30, 2017 2016.
Personal Injury Claim Advances [Policy Text Block]	Personal Injury Claim Advances Management assesses the quality of the personal injury claims portfolio through an analysis of the underlying personal injury fundings on a case by case basis. Cases are reviewed through periodic updates with attorneys handling the cases, as well as with third not
Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]	Goodwill Goodwill represents the excess of the purchase price over the fair value of the net assets acquired in a business combination, and is accounted for under ASC 350. fourth not not two 1 not no 2 2 $1.4 $1.4
Reclassification, Policy [Policy Text Block]	Reclassifications Certain prior period amounts in the accompanying consolidated financial statements have been reclassified to conform to the current year presentation. These reclassifications had no
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements In May 2014, 606, December 15, 2017 December 15, 2016, In January 2016, No. 2016 01, 825 10 December 15, 2017, In February 2016, No. 2016 02 842 December 15, 2018 may In March 2016, No. 2016 09, 718 December 15, 2016, In June 2016, 2016 13, 326 December 15, 2019. In August 2016, 2016 15, 230 eight December 15, 2017. not In November 2016, No. 2016 18, 2016 18" not 2016 18 not 2016 18 October 1, 2016, not In January 2017, 2017 04 350 2 December 15, 2019, not

Note 1 - Restatement of Finan31

Note 1 - Restatement of Financial Statements (Tables)	9 Months Ended
	Jun. 30, 2017
Notes Tables
Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]	Consolidated Balance Sheet June 30, 2017 As Reported De-Consolidation of Pegasus (1) Adjustments Restated ASSETS Cash and cash equivalents $ 15,315,000 $ (81,000 ) $ (21,000 ) (2) $ 15,213,000 Restricted cash 34,748,000 (24,748,000 ) — 10,000,000 Available for sale investments (at fair value) 5,500,000 — — 5,500,000 Consumer receivables acquired for liquidation (at net realizable value) 9,118,000 — 92,000 (2) 9,210,000 Investment in personal injury claims, net 27,538,000 (24,187,000 ) — 3,351,000 Due from third party collection agencies and attorneys 1,367,000 — (10,000 ) (2) 1,357,000 Prepaid and income taxes receivable 4,836,000 — 1,900,000 (5)(8) 6,736,000 Furniture and equipment, net 141,000 — — 141,000 Equity method investment — 48,639,000 (106,000 ) (7) 48,533,000 Deferred income taxes 18,940,000 — (4,820,000 ) (2)(8) 14,120,000 Goodwill 1,410,000 — — 1,410,000 Other assets 3,576,000 (109,000 ) (59,000 ) (2) 3,408,000 Assets related to discontinued operations 93,723,000 — (31,000 ) (5)(6) 93,692,000 Total assets $ 216,212,000 $ (486,000 ) $ (3,055,000 ) $ 212,671,000 LIABILITIES Line of credit 9,600,000 — — 9,600,000 Other liabilities 6,079,000 (755,000 ) (75,000 ) (2) 5,249,000 Liabilities related to discontinued operations 78,628,000 — 1,000 (4) 78,629,000 Total liabilities 94,307,000 (755,000 ) (74,000 ) 93,478,000 Commitments and contingencies STOCKHOLDERS’ EQUITY Preferred stock — — — — Common stock 134,000 — — 134,000 Additional paid-in capital 67,467,000 — 560,000 (5)(6) 68,027,000 Retained earnings 122,669,000 — (4,720,000 ) (2)(3)(4)(5)(6)(7)(8) 117,949,000 Accumulated other comprehensive income (loss) (968,000 ) — 1,179,000 (2) 211,000 Treasury stock (at cost) (67,128,000 ) — — (67,128,000 ) Non-controlling interest (269,000 ) 269,000 — — Total stockholders’ equity 121,905,000 269,000 (2,981,000 ) 119,193,000 Total liabilities and stockholders’ equity $ 216,212 ,000 $ (486,000 ) $ (3,055,000 ) $ 212,671,000 Consolidated Statement of Operations For the Three Months Ended June 30, 2017 As Reported De-Consolidation of Pegasus (1) Adjustments Restated Revenues: Finance income, net $ 3,980,000 $ — $ 13,000 (2) $ 3,993,000 Personal injury claims income 5,569,000 (5,328,000 ) — 241,000 Disability fee income 1,134,000 — — 1,134,000 Total revenues 10,683,000 (5,328,000 ) 13,000 5,368,000 Other income 84,000 — 6,000 (2) 90,000 10,767,000 (5,328,000 ) 19,000 5,458,000 General and administrative 7,252,000 (1,679,000 ) 493,000 (2)(6) 6,066,000 Interest 133,000 (2,000 ) 33,000 (2) 164,000 Impairment of consumer receivables 148,000 — — 148,000 Loss (earnings) from equity method investment — (2,917,000 ) 207,000 (7) (2,710,000 ) 7,533,000 (4,598,000 ) 733,000 3,668,000 Income (loss) from continuing operations before income tax 3,234,000 (730,000 ) (714,000 ) 1,790,000 Income tax (benefit)/expense 1,198,000 — (979,000 ) (8) 219,000 Net income (loss) from continuing operations 2,036,000 (730,000 ) 265,000 1,571,000 Income (loss) from discontinued operations, net of income tax 526,000 — 34,000 (3)(5)(8) 560,000 Less: net income attributable to non-controlling interests 730,000 (730,000 ) — — Net income attributable to Asta Funding, Inc. $ 1,832,000 $ — $ 299,000 $ 2,131,000 Net income (loss) per basic shares: Continuing operations $ 0.20 $ 0.24 Discontinued operations 0.08 0.08 $ 0.28 $ 0.32 Net income (loss) per diluted shares: Continuing operations $ 0.19 $ 0.23 Discontinued operations 0.08 0.08 $ 0.27 $ 0.31 Consolidated Statement of Operations For the Nine Months Ended June 30, 2017 As Reported De-Consolidation of Pegasus (1) Adjustments Restated Revenues: Finance income, net $ 11,999,000 $ — $ 19,000 (2) $ 12,018,000 Personal injury claims income 10,017,000 (9,766,000 ) — 251,000 Disability fee income 3,990,000 — — 3,990,000 Total revenues 26,006,000 (9,766,000 ) 19,000 16,259,000 Other income (74,000 ) — (52,000 ) (2) (126,000 ) 25,932,000 (9,766,000 ) (33,000 ) 16,133,000 General and administrative 31,354,000 (6,052,000 ) 309,000 (2)(6) 25,611,000 Interest 169,000 (6,000 ) 34,000 (2) 197,000 Impairment of consumer receivables 148,000 — — 148,000 Loss (earnings) from equity method investment — (2,966,000 ) 207,000 (7) (2,759,000 ) 31,671,000 (9,024,000 ) 550,000 23,197,000 (Loss) income from continuing operations before income tax (5,739,000 ) (742,000 ) (583,000 ) (7,064,000 ) Income tax (benefit)/expense (2,170,000 ) — 2,139,000 (8) (31,000 ) Net loss from continuing operations (3,569,000 ) (742,000 ) (2,722,000 ) (7,033,000 ) Loss from discontinued operations, net of income tax (1,083,000 ) — (673,000 ) (3)(5)(8) (1,756,000 ) Less: net income attributable to non-controlling interests 742,000 (742,000 ) — — Net loss attributable to Asta Funding, Inc. $ (5,394,000 ) $ — $ (3,395,000 ) $ (8,789,000 ) Net income (loss) per basic shares: Continuing operations $ (0.46 ) $ (0.75 ) Discontinued operations (0.11 ) (0.19 ) $ (0.57 ) $ (0.94 ) Net income (loss) per diluted shares: Continuing operations $ (0.46 ) $ (0.75 ) Discontinued operations (0.11 ) (0.19 ) $ (0.57 ) $ (0.94 ) Consolidated Statement of Comprehensive Income For the Three Months Ended June 30, 2017 As Reported De-Consolidation of Pegasus (1) Adjustments Restated Comprehensive income (loss) is as follows: Net income $ 1,832,000 $ — $ 299,000 $ 2,131,000 Net unrealized securities (loss) gain, net of tax 18,000 — — 18,000 Reclassification adjustments for securities sold, net of tax (11,000 ) — — (11,000 ) Foreign currency translation, net of tax (249,000 ) — 284,000 (2) 35,000 Other comprehensive (loss) income (242,000 ) — 284,000 42,000 Total comprehensive income $ 1,590,000 $ — $ 583,000 $ 2,173,000 Consolidated Statement of Comprehensive Loss For the Nine Months Ended June 30, 2017 As Reported De-Consolidation of Pegasus (1) Adjustments Restated Comprehensive (loss) income is as follows: Net loss $ (5,394,000 ) $ — $ (3,395,000 ) $ (8,789,000 ) Net unrealized securities (loss) gain, net of tax (17,000 ) — — (17,000 ) Reclassification adjustments for securities sold, net of tax (607,000 ) — — (607,000 ) Foreign currency translation, net of tax (430,000 ) — 462,000 (2)(6) 32,000 Other comprehensive (loss) income (1,054,000 ) 462,000 (592,000 ) Total comprehensive loss $ (6,448,000 ) $ $ (2,933,000 ) $ (9,381,000 ) Consolidated Statement of Cash Flows For the Nine Months Ended June 30, 2017 As Reported Adjustments Restated Cash flows from operating activities: Net loss from continuing operations $ (4,311,000 ) $ (2,722,000 ) $ (7,033,000 ) Net loss from discontinued operations (1,083,000 ) (673,000 ) (1,756,000 ) Net loss (5,394,000 ) (3,395,000 ) (8,789,000 ) Adjustments to reconcile net loss to net cash (used in) provided by operating activities: Depreciation and Amortization 154,000 (79,000 ) 75,000 Deferred income taxes (2,994,000 ) 4,193,000 (2)(8) 1,199,000 Impairments of consumer receivables acquired for liquidation 148,000 — 148,000 Stock based compensation 81,000 — 81,000 Loss on sale of available-for-sale securities 1,011,000 — 1,011,000 Unrealized gain on other investments 3,590,000 ) — 3,590,000 Earnings from equity method investment — (2,759,000 ) (7) (2,759,000 ) Forgiveness of debt — 552,000 (5) 552,000 Changes in: Prepaid and income taxes receivable (3,956,000 ) (2,066,000 ) (5)(8) (6,022,000 ) Due from third party collection agencies and attorneys (362,000 ) 42,000 (2) (320,000 ) Other assets 3,050,000 ) 134,000 (2) 3,184,000 Income tax payable (252,000 ) 252,000 (6) — Other liabilities 1,083,000 211,000 (2) 1,294,000 Non-controlling interest 742,000 (742,000 ) (1) — Net cash (used in) provided by operating activities of discontinued operations (3,654,000 ) 613,000 (5)(6) (3,041,000 ) Net cash (used in) provided by operating activities (6,753,000 ) (3,044,000 ) (9,797,000 ) Cash flows from investing activities: Purchase of consumer receivables acquired for liquidation (2,213,000 ) — (2,213,000 ) Principal collected on receivables acquired for liquidation 6,618,000 (294,000 ) (2) 6,324,000 Purchase of available-for-sale securities (13,193,000 ) — (13,193,000 ) Proceeds from sales of available-for-sale securities 62,406,000 — 62,406,000 Decrease in equity method investment — 2,808,000 (5)(6) 2,808,000 Investments in personal injury claims — advances (14,624,000 ) 11,273,000 (1) (3,351,000 ) Investments in personal injury claims — receipts 35,375,000 (35,375,000 ) (1) — Capital expenditures (19,000 ) — (19,000 ) Net cash provided by investing activities related to discontinued operations 1,548,000 — 1,548,000 Net cash provided by (used in) investing activities 75,898,000 (21,588,000 ) 54,310,000 Cash flows from financing activities: Purchase of treasury stock (54,203,000 ) — (54,203,000 ) Distributions to non-controlling interest (366,000 ) 366,000 (1) — Borrowings from line of credit 9,600,000 — 9,600,000 Net cash provided by financing activities related to discontinued operations 9,000,000 — 9,000,000 Net cash (used in) provided by financing activities (35,969,000 ) 366,000 (35,603,000 ) Foreign currency effect on cash — (37,000 ) (2) (37,000 ) Net increase in cash, cash equivalents and restricted cash including cash, cash equivalents classified within assets related to discontinued operations 33,176,000 (24,303,000 ) 8,873,000 Less: net decrease in cash, cash equivalents and restricted cash classified within assets related to discontinued operations 58,000 — 58,000 Net increase ( decrease ) in cash , cash equivalents and restricted cash 33,234,000 (24,303,000 ) (1)(2)(4)(5)(6)(7)(8) 8,931,000 Cash, cash equivalents and restricted cash at beginning of period 16,829,000 (547,000 ) 16,282,000 Cash , cash equivalents and restricted cash at end of period $ 50,063,000 $ (24,850,000 ) $ 25,213,000 Increase (decrease) in: Impact from September 30, 2016 10K/A filing Current period impact Cumulative net impact Cash and cash equivalents $3,000 $(24,000) $(21,000) Consumer receivables acquired for liquidation (245,000) 337,000 92,000 Due from third party collection agencies and attorneys 45,000 (55,000) (10,000) Deferred income taxes (722,000) (472,000) (1,194,000) Other assets (33,000) (26,000) (59,000) Other liabilities (18,000) (57,000) (75,000) Accumulated other comprehensive loss 718,000 461,000 1,179,000 Retained earnings (1,653,000) (645,000) (2,298,000) Increase (decrease) in: Impact from September 30, 2016 10K/A filing Current period impact Cumulative net impact Assets related to discontinued operations $307,000 $(357,000) $(50,000) Liabilities related to discontinued operations 756,000 (756,000) — Retained earnings (442,000) (155,000) (597,000) Additional paid in capital - 552,000 552,000 Increase (decrease) in: Impact from September 30, 2016 10K/A filing Current period impact Cumulative net impact Other liabilities $269,000 $(269,000) $ — Retained earnings (137,000) 270,000 133,000 Assets related to discontinued operations 45,000 - 45,000 Additional paid in capital 8,000 - 8,000

Note 3 - Available-for-sale I32

Note 3 - Available-for-sale Investments (Tables)	9 Months Ended
	Jun. 30, 2017
Notes Tables
Available-for-sale Securities [Table Text Block]	Amortized Cost Unrealized Gains Unrealized Losses Fair Value June 30, 2017 $ 5,500,000 $ - $ - $ 5,500,000 September 30, 2016 $ 55,724,000 $ 1,088,000 $ (49,000 ) $ 56,763,000

Note 4 - Consumer Receivables33

Note 4 - Consumer Receivables Acquired for Liquidation (Tables)	9 Months Ended
	Jun. 30, 2017
Notes Tables
Schedule of Consumer Receivables after Liquidation [Table Text Block]	For the Three Months Ended June 30, 2017 2016 Balance, beginning of period $ 11,590,000 $ 16,440,000 Acquisitions of receivable portfolio — 751,000 Net cash collections from collection of consumer receivables acquired for liquidation (6,061,000 ) (7,286,000 ) Net cash collections represented by account sales of consumer receivables acquired for liquidation (1,000 ) (83,000 ) Impairment (148,000 ) — Effect of foreign currency translation (163,000 ) 92,000 Finance income recognized 3,993,000 4,571,000 Balance, end of period $ 9,210,000 $ 14,485,000 Finance income as a percentage of collections 65.9 % 62.0 % For the Nine Months Ended June 30, 2017 2016 Balance, beginning of period $ 13,427,000 $ 15,056,000 Acquisitions of receivable portfolio 2,213,000 6,936,000 Net cash collections from collection of consumer receivables acquired for liquidation (18,148,000 ) (22,060,000 ) Net cash collections represented by account sales of consumer receivables acquired for liquidation (191,000 ) (83,000 ) Impairment (148,000 ) (124,000 ) Effect of foreign currency translation 39,000 205,000 Finance income recognized 12,018,000 14,555,000 Balance, end of period $ 9,210,000 $ 14,485,000 Finance income as a percentage of collections 65.5 % 65.7 %
Schedule of Collections on Gross Basis [Table Text Block]	For the Three Months Ended June 30, For the Nine Months Ended June 30, 2017 2016 2017 2016 Gross collections (1) $ 10,659,000 $ 12,380,000 32,641,000 36,982,000 Commissions and fees (2) 4,597,000 5,011,000 14,302,000 14,839,000 Net collections $ 6,062,000 $ 7,369,000 $ 18,339,000 $ 22,143,000

Note 5 - Litigation Funding (Ta

Note 5 - Litigation Funding (Tables)	9 Months Ended
	Jun. 30, 2017
Notes Tables
Equity Method Investments [Table Text Block]	June 3 0 , 2017 September 30, 2016 Carrying Value Ownership Percentage Carrying Value Ownership Percentage Pegasus Funding, LLC $ 48,533,000 80 % $ 48,582,000 80 %
Equity Method Investment, Summarized Financial Information [Table Text Block]	Condensed Statement of Operations Information Three months ended June 30 , 201 7 June 30 , 201 6 Personal injury claims income $ 5,068,000 $ 9,838,000 Operating expenses 1,680,000 2,096,000 Income from operations $ 3,388,000 $ 7,742,000 Earnings from equity investment $ 2,710,000 $ 6,193,000 Condensed Statement of Operations Information Nine months ended June 30, 2017 June 30, 2016 Personal injury claims income $ 9,507,000 $ 14,769,000 Operating expenses 6,058,000 4,744,000 Income from operations $ 3,449,000 $ 10,025,000 Company’s equity income from operations $ 2,759,000 $ 8,020,000 Condensed Balance Sheet Information June 30 , 201 7 September 30, 2016 Cash $ 24,829,000 (1) $ 539,000 Investment in personal injury claims 23,927,000 48,289,000 Other assets 109,000 188,000 Total assets $ 48,865,000 $ 49,016,000 Due to Asta $ 31,596,000 $ 34,404,000 Other liabilities 628,000 1,053,000 Equity 16,641,000 13,559,000 Total liabilities and equity $ 48,865,000 $ 49,016,000

Note 6 - Furniture & Equipment

Note 6 - Furniture & Equipment (Tables)	9 Months Ended
	Jun. 30, 2017
Notes Tables
Property, Plant and Equipment [Table Text Block]	June 30, September 30, 2017 2016 Furniture $ 273,000 $ 273,000 Equipment 242,000 235,000 Software 1,363,000 1,350,000 1,878,000 1,858,000 Less accumulated depreciation and amortization 1,737,000 1,662,000 Balance, end of period $ 141,000 $ 196,000

Note 8 - Discontinued Operati36

Note 8 - Discontinued Operations (Tables)	9 Months Ended
	Jun. 30, 2017
Notes Tables
Disposal Groups, Including Discontinued Operations [Table Text Block]	Three months ended June 30, 2017 June 30, 2016 Revenues: Unrealized gain on structured settlements $ 7,531,000 $ 1,422,000 Interest income on structured settlements 1,923,000 1,765,000 Loss on sale of structured settlements (5,353,000 ) — Total revenues 4,101,000 3,187,000 Other income 14,000 46,000 4,115,000 3,233,000 Expenses: General and administrative expenses 2,156,000 1,406,000 Interest expense 990,000 833,000 3,146,000 2,239,000 Income from discontinued operations before income tax 969,000 994,000 Income tax expense from discontinued operations 409,000 417,000 Income from discontinued operations, net of income tax $ 560,000 $ 577,000 Nine months ended June 30, 2017 June 30, 2016 Revenues: Unrealized gain on structured settlements $ 4,511,000 $ 4,586,000 Interest income on structured settlements 5,765,000,000 4,473,000 Loss on sale of structured settlements (5,353,000 ) — Total revenues 4,923,000 9,059,000 Other income 44,000 46,000 4,967,000 9,105,000 Expenses: General and administrative expenses 5,152,000 4,157,000 Interest expense 2,871,000 2,349,000 8,023,000 6,506,000 (Loss) income from discontinued operations before income tax (3,056,000 ) 2,599,000 Income tax (benefit) expense from discontinued operations (1,300,000 ) 1,091,000 (Loss) income from discontinued operations before non-controlling interest (1,756,000 ) 1,508,000 Non-controlling interest — 104,000 (Loss) income from discontinued operations, net of income tax $ (1,756,000 ) $ 1,404,000 June 30, 2017 September 30, 2016 Cash and cash equivalents $ 1,256,000 (1) $ 1,198,000 Restricted cash 499,000 499,000 Structured settlements 88,268,000 86,091,000 Furniture and equipment, net 37,000 47,000 Goodwill 1,405,000 1,405,000 Other assets 2,227,000 2,266,000 Total assets related to discontinued operations $ 93,692,000 $ 91,506,000 Other debt - CBC 76,435,000 67,435,000 Other liabilities 2,194,000 1,803,000 Total liabilities related to discontinued operations $ 78,629,000 $ 69,238,000
Structured Settlements [Table Text Block]	June 30, 2017 September 30, 2016 Maturity (1) (2) $ 135,132,000 $ 133,059,000 Unearned income (46,864,000 ) (46,968,000 ) Structured settlements, net $ 88,268,000 $ 86,091,000
Schedule of Fair Value of Debt [Table Text Block]	Interest Rate June 30, 2017 September 30, 2016 Notes payable secured by settlement receivables with principal and interest outstanding payable until June 2025 (3) 8.75 % $ 1,716,000 $ 1,862,000 Notes payable secured by settlement receivables with principal and interest outstanding payable until August 2026 (3) 7.25 % 3,947,000 4,242,000 Notes payable secured by settlement receivables with principal and interest outstanding payable until April 2032 (3) 7.125 % 3,907,000 3,987,000 Notes payable secured by settlement receivables with principal and interest outstanding payable until February 2037 (3) 5.39 % 17,765,000 18,978,000 Notes payable secured by settlement receivables with principal and interest outstanding payable until March 2034 (3) 5.07 % 13,780,000 14,507,000 Notes payable secured by settlement receivables with principal and interest outstanding payable until February 2043 (3) 4.85 % 13,259,000 13,705,000 Notes payable secured by settlement receivables with principal and interest outstanding payable until January 2069 (3) 5.0 % 17,761,000 — $25,000,000 revolving line of credit (3) 4.1 % 4,300,000 10,154,000 Encumbered structured settlements 76,435,000 67,435,000 Structured settlements not encumbered 11,833,000 18,656,000 Total structured settlements $ 88,268,000 $ 86,091,000
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	September 30, 2017 (3 months) $ 2,679,000 September 30, 2018 9,020,000 September 30, 2019 9,312,000 September 30, 2020 8,989,000 September 30, 2021 9,474,000 Thereafter 95,658,000 Total $ 135,132,000

Note 12 - Net Income (Loss) P37

Note 12 - Net Income (Loss) Per Share (Tables)	9 Months Ended
	Jun. 30, 2017
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended June 30, 2017 Three Months Ended June 30, 2016 Net Income Weighted Average Shares Per Share Amount Net Income Weighted Average Shares Per Share Amount Net (loss) income from continuing operations $ 1,571,000 6,577,784 $ 0.24 $ 3,289,000 11,897,139 $ 0.27 Net (loss) income from discontinued operations 560,000 6,577,784 0.08 577,000 11,897,139 0.05 $ 2,131,000 $ 0.32 $ 3,866,000 $ 0.32 Effect of Dilutive Stock 301,298 (0.01 ) 536,285 (0.01 ) Diluted $ 2,131,000 6,879,082 $ 0.31 $ 3,866,000 12,433,424 $ 0.31 Nine Months Ended June, 2017 Nine Months Ended June 30, 2016 Net Loss Weighted Average Shares Per Share Amount Net Income Weighted Average Shares Per Share Amount Net (loss) income from continuing operations $ (7,033,000 ) 9,389,864 $ (0.75 ) $ 2,195,000 12,023,156 $ 0.18 Net (loss) income from discontinued operations (1,756,000 ) 9,389,864 (0.19 ) 1,404,000 12,023,156 0.12 $ (8,789,000 ) (0.94 ) 3,599,000 $ 0.30 Effect of Dilutive Stock — — 270,917 (0.01 ) Diluted $ (8,789,000 ) 9,389,864 $ (0.94 ) $ 3,599,000 12,294,073 $ 0.29

Note 13 - Stock Based Compens38

Note 13 - Stock Based Compensation (Tables)	9 Months Ended
	Jun. 30, 2017
Notes Tables
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	Risk-free interest rate 0.24 % Expected term (years) 6.25 Expected volatility 23.4 % Dividend yield 0.00 % Risk-free interest rate 1.86 % Expected term (years) 5.97 Expected volatility 26.27 % Forfeiture rate 3.49 % Dividend yield 0.00 %

Note 14 - Stock Option Plans (T

Note 14 - Stock Option Plans (Tables)	9 Months Ended
	Jun. 30, 2017
Notes Tables
Share-based Compensation, Stock Options, Activity [Table Text Block]	Nine Months Ended June 30, 2017 2016 Number Of Shares Weighted Average Exercise Price Number of Shares Weighted Average Exercise Price Outstanding options at the beginning of period 949,667 $ 8.47 1,043,566 $ 8.47 Options granted 56,600 6.55 67,100 7.93 Options exercised — — (107,531 ) 8.11 Options forfeited/cancelled (53,800 ) 14.01 (8,300 ) 8.14 Outstanding options at the end of period 952,467 $ 8.05 994,835 $ 8.47 Exercisable options at the end of period 867,195 $ 8.13 874,826 $ 8.51 Three Months Ended June 30, 2017 2016 Number Of Shares Weighted Average Exercise Price Number of Shares Weighted Average Exercise Price Outstanding options at the beginning of period 896,867 $ 8.14 1,094,867 $ 8.45 Options granted 56,600 6.55 — — Options exercised — — (100,032 ) 8.24 Options forfeited/cancelled (1,000 ) 7.93 — — Outstanding options at the end of period 952,467 $ 8.05 994,835 $ 8.47 Exercisable options at the end of period 867,195 $ 8.13 874,826 $ 8.51
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]	Options Outstanding Options Exercisable Range of Exercise Price Number of Shares Outstanding Weighted Remaining Contractual Life (in Years) Weighted Average Exercise Price Number of Shares Exercisable Weighted Average Exercise Price $2.8751 – $4.3000 3,800 1.8 2.95 3,800 $ 2.95 $5.7501 – $8.6250 824,167 5.1 7.86 738,895 7.94 $8.6251 – $11.5000 124,500 5.6 9.40 124,500 9.40 952,467 5.1 8.05 867,195 $ 8.13
Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]	Nine Months Ended June 30, 2017 2016 Number of Shares Weighted Average Grant Date Fair Value Number of Shares Weighted Average Grant Date Fair Value Unvested at the beginning of period — $ — 44,107 $ 9.28 Awards granted — — 128,304 7.89 Vested — — (39,107 ) 9.57 Forfeited — — — — Unvested at the end of period — $ — 133,304 $ 7.92 Three Months Ended June 30, 2017 2016 Number of Shares Weighted Average Grant Date Fair Value Number of Shares Weighted Average Grant Date Fair Value Unvested at the beginning of period — $ — 138,304 $ 7.92 Awards granted — — — — Vested — — (5,000 ) — Forfeited — — — Unvested at the end of period — $ — 133,304 $ 7.92

Note 16 - Fair Value of Finan40

Note 16 - Fair Value of Financial Measurements and Disclosures (Tables)	9 Months Ended
	Jun. 30, 2017
Notes Tables
Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]	June 30, 2017 September 30, 2016 Carrying Amount Fair Value Carrying Amount Fair Value Financial assets Cash equivalents (Level 1) $ 2,864,000 $ 2,864,000 $ 923,000 $ 923,000 Available-for-sale investments (Level 1) 5,500,000 5,500,000 56,764,000 56,764,000 Other investments, net (Level 1) — — 3,590,000 3,590,000 Consumer receivables acquired for liquidation (Level 3) 9,210,000 41,488,000 13,427,000 47,233,000 June 30, 2017 September 30, 2016 Carrying Fair Carrying Fair Financial asset Structured settlements (Level 3) 88,268,000 88,268,000 86,091,000 86,091,000
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]	Fair Value Valuation Technique Significant Unobservable Input Weighted Average Rate Structured settlements at fair value $ 88,268,000 Discounted cash flow Discount rate 4.71% – 6.05%
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	Structured Settlement Balance at September 30, 2016 $ 86,091,000 Fair value adjustment (433,000 ) Total gains and losses included in earnings (842,000 ) Changes in allowance 242,000 Purchases 13,363,000 Sales (7,727,000 ) Interest accreted 4,760,000 Payments received (7,186,000 ) Total $ 88,268,000
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Table Text Block]	The amount of total gains for the nine months period included in earnings attributable to the change in unrealized gains relating to assets held at June 30, 2017 $ 4,511,000 Realized loss relating to assets sold during the nine months ended June 30, 2017 $ (5,353,000 ) Total losses included in the nine months ended June 30, 2017 $ (842,000 )

Note 17 - Segment Reporting (Ta

Note 17 - Segment Reporting (Tables)	9 Months Ended
	Jun. 30, 2017
Notes Tables
Schedule of Segment Reporting Information, by Segment [Table Text Block]	(Dollars in millions) Consumer GAR Disability Personal Injury Claims Including Equity Investment (2) Corporate (3) Total Three Months Ended June 30, 2017: Revenues $ 4.0 $ 1.1 $ 0.3 $ — $ 5.4.4 Other income — — — — 0.1 Segment profit (loss) 2.9 0.0 2.6 (3.7 ) 1.8 2016: Revenues 4.6 1.2 — — 5.8 Other income — — — 0.2 0.2 Segment profit (loss) 4.2 (1.8 ) 6.2 (3.6 ) 5.0 Nine Months Ended June 30, 2017: Revenues $ 12.0 $ 4.0 $ 0.3 $ — $ 16.3.4 Other income — — — (0.1 ) (0.1 ) Segment profit (loss) 9.7 (1.4 ) 2.3 (17.7 ) (7.1 ) Segment Assets(1) 19.6 3.3 52.9 136.9 (4) 212.7 2016: Revenues 14.6 2.7 — — 17.3 Other income — — — 1.2 1.2 Segment profit (loss) 10.7 (6.3 ) 8.0 (9.1 ) 3.3 Segment Assets(1) 19.2 1.5 45.1 180.8 (4) 246.6

Note 18 - Accumulated Other C42

Note 18 - Accumulated Other Comprehensive (Loss) Income (Tables)	9 Months Ended
	Jun. 30, 2017
Notes Tables
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	Nine Months Ended June 30, 2017 Year Ended September 30, 2016 Unrealized Gain (loss) on marketable securities Foreign currency translation, net Total Unrealized Gain (loss) on marketable securities Foreign currency translation, net Total Beginning Balance $ 624,000 $ 179,000 $ 803,000 $ (205,000 ) $ 225,000 $ 20,000 Change in unrealized (losses) gains on foreign currency translation, net of tax benefit/(expense) of ($21,000) and $31,000 at June 30 2017, and September 30, 2016, respectively. — 32,000 32,000 — (46,000 ) (46,000 ) Change in unrealized (losses) gains on marketable securities, net of tax benefit/ (expense) of $404,000 and ($529,000) at June 30 2017, and September 30, 2016, respectively. (607,000 ) — (607,000 ) 868,000 — 868,000 Amount reclassified from accumulated other comprehensive loss, net of tax benefit of $11,000 and $24,000 at June 30 2017, and September 30, 2016, respectively. (17,000 ) — (17,000 ) (39,000 ) — (39,000 ) Net current-period other comprehensive (loss) income (624,000 ) 32,000 (592,000 ) 829,000 (46,000 ) $ 783,000 Ending balance $ — $ 211,000 $ 211,000 $ 624,000 $ 179,000 $ 803,000 Nine Months Ended June 30, 2016 Unrealized Gain (loss) on marketable securities Foreign currency translation, net Total Beginning Balance $ (205,000 ) $ 225,000 $ 20,000 Change in unrealized (losses) gains on foreign currency translation, net of tax benefit/(expense) of $25,000 during the nine month period ended June 30, 2016. - (37,000 ) (37,000 ) Change in unrealized (losses) gains on marketable securities, net of tax benefit/ (expense) of ($695,000) during the nine month period ended June 30, 2016. 1,046,000 - 1,046,000 Amount reclassified from accumulated other comprehensive loss, net of tax benefit of $24,000 during the nine month period ended June 30, 2016. (39,000 ) - (39,000 ) Net current-period other comprehensive (loss) income 1,007,000 (37,000 ) 970,000 Ending balance $ 802,000 $ 188,000 $ 990,000

Note 1 - Restatement of Finan43

Note 1 - Restatement of Financial Statements (Details Textual) - USD ($)		3 Months Ended			9 Months Ended
		Jun. 30, 2017		Jun. 30, 2016	Jun. 30, 2017		Jun. 30, 2016	Dec. 31, 2016	Sep. 30, 2016
Other Long-term Investments		$ 3,351,000			$ 3,351,000
Other Assets, Total		3,408,000			3,408,000				6,585,000
Other Liabilities, Total		5,249,000			5,249,000				3,987,000
Stockholders' Equity Attributable to Noncontrolling Interest, Ending Balance
Equity Method Investments		48,533,000			48,533,000				48,582,000
Revenues, Total		5,458,000		$ 5,917,000	16,133,000		$ 18,433,000
General and Administrative Expense, Total		6,066,000		7,069,000	25,611,000		23,020,000
Net Income (Loss) Attributable to Noncontrolling Interest, Total
Income (Loss) from Equity Method Investments, Total		2,710,000		6,193,000	2,759,000		6,193,000
Revenue, Net (Deprecated 2018-01-31)		5,368,000		5,741,000	16,259,000		17,257,000
Other Nonoperating Income		90,000
Interest Expense, Total		164,000			197,000
Disposal Group, Including Discontinued Operation, Assets, Total		93,692,000			93,692,000				91,506,000
Retained Earnings (Accumulated Deficit), Ending Balance		117,949,000			117,949,000				126,738,000
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities, Carrying Amount, Net		9,210,000		14,500,000	9,210,000		14,500,000		13,427,000
Income Taxes Receivable		6,736,000			6,736,000				714,000
Deferred Tax Assets, Net of Valuation Allowance, Total		14,120,000			14,120,000				14,903,000
Income Tax Expense (Benefit), Total		219,000		$ 1,752,000	(31,000)		$ 1,114,000
Pegasus Funding LLC [Member]
Equity Method Investments		48,533,000			48,533,000				48,582,000
Restatement Adjustment [Member]
Income (Loss) from Equity Method Investments, Total	[1]				2,759,000
Restatement Adjustment [Member] | Accounting For Investment in Pegasus Under The Equity Method [Member]
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Ending Balance								$ (24,829,000)
Other Long-term Investments		(24,187,000)	[2]		(24,187,000)	[2]		(24,187,000)
Other Assets, Total		(109,000)	[2]		(109,000)	[2]		(109,000)
Other Liabilities, Total		(755,000)	[2]		(755,000)	[2]		(755,000)
Stockholders' Equity Attributable to Noncontrolling Interest, Ending Balance		269,000	[2]		269,000	[2]		269,000
Equity Method Investments	[2]	48,639,000			48,639,000
Revenues, Total	[2]	(5,328,000)			(9,766,000)
General and Administrative Expense, Total		(1,681,000)			(6,058,000)
Net Income (Loss) Attributable to Noncontrolling Interest, Total	[2]	(730,000)			(742,000)
Income (Loss) from Equity Method Investments, Total	[2]	2,917,000			2,966,000
Revenue, Net (Deprecated 2018-01-31)	[2]	(5,328,000)			(9,766,000)
Other Nonoperating Income	[2]
Interest Expense, Total	[2]	(2,000)			(6,000)
Disposal Group, Including Discontinued Operation, Assets, Total	[2]
Retained Earnings (Accumulated Deficit), Ending Balance	[2]
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities, Carrying Amount, Net	[2]
Income Taxes Receivable	[2]
Deferred Tax Assets, Net of Valuation Allowance, Total	[2]
Income Tax Expense (Benefit), Total	[2]
Restatement Adjustment [Member] | Foreign Currency Gains/Losses On Intercompany Balances and Transactions Corrections [Member]
General and Administrative Expense, Total		493,000			580,000
Revenue, Net (Deprecated 2018-01-31)		13,000			19,000
Other Nonoperating Income		6,000			(52,000)
Interest Expense, Total		34,000			34,000
Restatement Adjustment [Member] | Revision of The Fair Market of The Structured Settlements [Member]
Structured Settlements, Fair Value								(2,600,000)
Prepaid Income Taxes and Deferred Tax Assets								1,000,000
Disposal Group, Including Discontinued Operation, Assets, Total								$ 727,000
Retained Earnings (Accumulated Deficit), Ending Balance		727,000			727,000
Restatement Adjustment [Member] | Addition of Certain Unallocated Payments [Member]
Retained Earnings (Accumulated Deficit), Ending Balance									(648,000)
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities, Carrying Amount, Net									$ (648,000)
Restatement Adjustment [Member] | Correction Of An Amortizable Asset and Related Liability In Conjunction With An Asset Purchase Agreement Entered Into In June 2015 With a Related Party [Member]
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest, Total		(34,000)			(153,000)
Restatement Adjustment [Member] | Correction of Other Liabilities That Had Not Been Properly Accrued To The Correct Period And/Or In Improper Amounts [Member]
General and Administrative Expense, Total		0			(271,000)
Restatement Adjustment [Member] | Correction of Personal Injury Claims Assets Balance of Equity Investment [Member] | Pegasus Funding LLC [Member]
Income (Loss) from Equity Method Investments, Total		0			320,000
Restatement Adjustment [Member] | Correction of Personal Injury Claims Assets Balance of Equity Investment, Impact of Related Accruals [Member] | Pegasus Funding LLC [Member]
Equity Method Investments		101,000			101,000
Income (Loss) from Equity Method Investments, Total		(207,000)			(207,000)
Restatement Adjustment [Member] | Tax Impact of Errors Correction [Member]
Income Taxes Receivable		(1,875,000)			(1,875,000)
Deferred Tax Assets, Net of Valuation Allowance, Total		(3,627,000)			(3,627,000)
Income Tax Expense (Benefit), Total		(979,000)			2,139,000
Discontinued Operation, Tax Effect of Discontinued Operation, Total		$ 93,000			$ (233,000)
[1]	The Company identified the personal injury claims asset balance of Pegasus was determined to be overstated at March 31, 2017 by $400,000. The correction of this error resulted in a decrease in earnings from the equity investment in Pegasus and income from continuing operations of $0 and $320,000 for the three and nine months ended June 30, 2017. Additionally, the equity investment was increased $101,000 to reflect the impact of the related accruals in the September 30, 2016 Form 10-K/A. During the three and nine months ended June 30, 2017, earnings from equity method investment decreased by $207,000 for a reduction in personal injury claims in Pegasus.
[2]	In connection with the Company determining it lacked the requisite control to consolidate Pegasus during the Non-Reliance Period, the Company has now accounted for its investment in Pegasus under the equity method in accordance with US GAAP. On the Company's June 30, 2017 consolidated balance sheet, this resulted in (i) a decrease in cash and restricted cash of $24,829,000; (ii) a decrease in the investment in personal injury claims of $24,187,000; (iii) a decrease in other assets of $109,000; (iv) a decrease in other liabilities of $755,000; and (v) a decrease in non-controlling interest of $269,000, offset by a corresponding increase in the equity method investment of $48,639,000. On the Company's consolidated statement of operations, this resulted in (i) a decrease in total revenues of $5,328,000; (ii) a decrease in expenses of $1,681,000; (iii) a decrease in the income attributable to the non-controlling interest of $730,000; and (iv) a decrease in earnings from equity method investment of $2,917,000 the three months ended June 30, 2017. This change to the equity method of accounting had no effect on net (loss) income attributable to Asta Funding, Inc. during the Non-Reliance Period. On the Company's consolidated statement of operations, this resulted in (i) a decrease in total revenues of $9,766,000; (ii) a decrease in expenses of $6,058,000; (iii) a decrease in the income attributable to the non-controlling interest of $742,000; and (iv) a decrease in earnings from equity method investment of $2,966,000 the nine months ended June 30, 2017. This change to the equity method of accounting had no effect on net (loss) income attributable to Asta Funding, Inc. during the Non-Reliance Period.

Note 1 - Restatement of Finan44

Note 1 - Restatement of Financial Statements - Adjustments to the Financial Statements (Details) - USD ($)		3 Months Ended				9 Months Ended				12 Months Ended
		Jun. 30, 2017		Jun. 30, 2016		Jun. 30, 2017		Jun. 30, 2016		Sep. 30, 2016	Dec. 31, 2016	Sep. 30, 2015
Cash and cash equivalents		$ 15,213,000				$ 15,213,000				$ 6,282,000
Restricted cash		10,000,000				10,000,000				10,000,000
Available for sale investments (at fair value)		5,500,000				5,500,000				56,763,000
Consumer receivables acquired for liquidation (at net realizable value)		9,210,000		$ 14,500,000		9,210,000		$ 14,500,000		13,427,000
Investment in personal injury claims, net		3,351,000				3,351,000
Due from third party collection agencies and attorneys		1,357,000				1,357,000				1,050,000
Prepaid and income taxes receivable		6,736,000				6,736,000				714,000
Furniture and equipment, net		141,000				141,000				196,000
Equity method investment		48,533,000				48,533,000				48,582,000
Deferred income taxes		14,120,000				14,120,000				14,903,000
Goodwill		1,410,000				1,410,000				1,410,000
Other assets		3,408,000				3,408,000				6,585,000
Assets related to discontinued operations		93,692,000				93,692,000				91,506,000
Total assets		212,671,000		246,600,000	[1]	212,671,000		246,600,000	[1]	255,008,000
Line of credit		9,600,000				9,600,000
Other liabilities		5,249,000				5,249,000				3,987,000
Liabilities related to discontinued operations		78,629,000				78,629,000				69,238,000
Total liabilities		93,478,000				93,478,000				73,225,000
Commitments and contingencies
Preferred stock
Common stock		134,000				134,000				133,000
Additional paid-in capital		68,027,000				68,027,000				67,034,000
Retained earnings		117,949,000				117,949,000				126,738,000
Accumulated other comprehensive income		211,000				211,000				803,000
Treasury stock (at cost)		(67,128,000)				(67,128,000)				(12,925,000)
Non-controlling interest
Total stockholders’ equity		119,193,000		177,544,000		119,193,000		177,544,000		181,783,000		$ 183,407,000
Total liabilities and stockholders’ equity		212,671,000				212,671,000				255,008,000
Finance income recognized		3,993,000		4,572,000		12,018,000		14,557,000
Personal injury claims income		241,000				251,000
Disability fee income		1,134,000		1,169,000		3,990,000		2,700,000
Total revenues		5,368,000		5,741,000		16,259,000		17,257,000
Other Nonoperating Income		90,000
Revenues, Total		5,458,000		5,917,000		16,133,000		18,433,000
General and administrative		6,066,000		7,069,000		25,611,000		23,020,000
Interest		164,000				197,000
Impairment of consumer receivables		148,000				148,000		124,000
Loss (earnings) from equity method investment		(2,710,000)		(6,193,000)		(2,759,000)		(6,193,000)
		3,668,000		876,000		23,197,000		15,124,000
Income (loss) from continuing operations before income tax		1,790,000		5,041,000		(7,064,000)		3,309,000
Income Tax Expense (Benefit), Total		219,000		1,752,000		(31,000)		1,114,000
Net income (loss) from continuing operations		1,571,000		3,289,000		(7,033,000)		2,195,000
Net income (loss) from discontinued operations, net of income tax		560,000		577,000		(1,756,000)		1,404,000
Net Income (Loss) Attributable to Noncontrolling Interest, Total
Net income (loss)		$ 2,131,000		$ 3,866,000		$ (8,789,000)		$ 3,599,000
Continuing operations (in dollars per share)		$ 0.24		$ 0.27		$ (0.75)		$ 0.18
Discontinued operations (in dollars per share)		0.08		0.05		(0.19)		0.12
Basic, per share amount (in dollars per share)		0.32		0.32		(0.94)		0.30
Continuing operations (in dollars per share)		0.23		0.26		(0.75)		0.18
Discontinued operations (in dollars per share)		0.08		0.05		(0.19)		0.11
Diluted, per share amount (in dollars per share)		$ 0.31		$ 0.31		$ (0.94)		$ 0.29
Other income		$ 90,000		$ 176,000		$ (126,000)		$ 1,176,000
Net (loss) income from continuing operations		1,571,000		3,289,000		(7,033,000)		2,195,000
Net loss attributable to Asta Funding, Inc.		$ 2,131,000		$ 3,866,000		$ (8,789,000)		$ 3,599,000
Continuing operations (in dollars per share)						$ (0.75)
Discontinued operations (in dollars per share)						(0.19)
(in dollars per share)						(0.94)
(in dollars per share)		$ 0.31		$ 0.31		$ (0.94)		$ 0.29
Change in unrealized (losses) gains on marketable securities, net of tax benefit/ (expense)		$ 18,000		$ 560,000		$ (17,000)		$ 1,046,000
Amount reclassified from other comprehensive (loss) income		(11,000)		(19,000)		(607,000)		(39,000)
Foreign currency translation, net		35,000		(63,000)		32,000		(37,000)
Other comprehensive (loss) income		42,000		478,000		(592,000)		970,000
Total comprehensive income		2,173,000		4,344,000		(9,381,000)		4,569,000
Depreciation and Amortization						75,000		353,000
Deferred income taxes						1,199,000		(78,000)
Stock based compensation						81,000		567,000
Loss on sale of available-for-sale securities		18,000		32,000		1,011,000		63,000
Unrealized gain on other investments								(246,000)
Earnings from equity method investment		(2,710,000)		(6,193,000)		(2,759,000)		(6,193,000)
Forgiveness of debt						552,000
Prepaid and income taxes receivable						(6,022,000)		2,512,000
Due from third party collection agencies and attorneys						(320,000)		376,000
Other assets						3,184,000		(2,444,000)
Income tax payable
Other liabilities						1,294,000		1,911,000
Non-controlling interest
Net cash used in operating activities of discontinued operations						(3,041,000)		(6,649,000)
Net cash (used in) provided by operating activities						(9,797,000)		(5,025,000)
Purchase of consumer receivables acquired for liquidation				(751,000)		(2,213,000)		(6,936,000)
Principal collected on receivables acquired for liquidation						6,324,000		7,384,000
Purchase of available-for-sale securities						(13,193,000)		(11,704,000)
Proceeds from sale of available-for-sale securities						62,406,000		16,302,000
(Increase) decrease in equity method investment						2,808,000		1,826,000
Investments in personal injury claims — advances						(3,351,000)
Investments in personal injury claims — receipts
Capital expenditures						(19,000)		(120,000)
Net cash provided by (used in) investing activities of discontinued operations						1,548,000		(6,756,000)
Net cash provided by (used in) investing activities						54,310,000		(804,000)
Purchase of treasury stock						(54,203,000)		(11,174,000)
Distributions to non-controlling interest
Borrowings from line of credit						9,600,000
Net cash provided by financing activities of discontinued operations						9,000,000		11,056,000
Net cash (used in) provided by financing activities						(35,603,000)		754,000
Foreign currency effect on cash						(37,000)
Net increase in cash, cash equivalents and restricted cash including cash, cash equivalents classified within assets related to discontinued operations						8,873,000		(5,075,000)
Less: net decrease in cash, cash equivalents and restricted cash classified within assets related to discontinued operations						58,000		(283,000)
Net increase (decrease) in cash, cash equivalents and restricted cash						8,931,000		(5,358,000)
Cash, cash equivalents and restricted cash at beginning of period						16,282,000		19,947,000		19,947,000
Cash, cash equivalents and restricted cash at end of period		25,213,000		$ 14,589,000		25,213,000		$ 14,589,000		16,282,000
Correction of Foreign Currency Transaction, Impact from September 30, 2016 10K/A Filing [Member]
Cash and cash equivalents		3,000				3,000
Consumer receivables acquired for liquidation (at net realizable value)		(245,000)				(245,000)
Due from third party collection agencies and attorneys		45,000				45,000
Deferred income taxes		(722,000)				(722,000)
Other assets		(33,000)				(33,000)
Other liabilities		(18,000)				(18,000)
Retained earnings		(1,653,000)				(1,653,000)
Accumulated other comprehensive income		718,000				718,000
Correction of Foreign Currency Transaction, Current Period Impact [Member]
Cash and cash equivalents		(24,000)				(24,000)
Consumer receivables acquired for liquidation (at net realizable value)		337,000				337,000
Due from third party collection agencies and attorneys		(55,000)				(55,000)
Deferred income taxes		(472,000)				(472,000)
Other assets		(26,000)				(26,000)
Other liabilities		(57,000)				(57,000)
Retained earnings		(645,000)				(645,000)
Accumulated other comprehensive income		461,000				461,000
Correction of Foreign Currency Transaction, Cumulative Net Impact [Member]
Cash and cash equivalents		(21,000)				(21,000)
Consumer receivables acquired for liquidation (at net realizable value)		92,000				92,000
Due from third party collection agencies and attorneys		(10,000)				(10,000)
Deferred income taxes		(1,194,000)				(1,194,000)
Other assets		(59,000)				(59,000)
Other liabilities		(75,000)				(75,000)
Retained earnings		(2,298,000)				(2,298,000)
Accumulated other comprehensive income		1,179,000				1,179,000
Correction of Amortizable Asset and Related Liability, Impact from September 30, 2016 10K/A Filing [Member]
Assets related to discontinued operations		307,000				307,000
Liabilities related to discontinued operations		756,000				756,000
Additional paid-in capital
Retained earnings		(442,000)				(442,000)
Correction of Amortizable Asset and Related Liability, Current Period Impact [Member]
Assets related to discontinued operations		(357,000)				(357,000)
Liabilities related to discontinued operations		(756,000)				(756,000)
Additional paid-in capital		552,000				552,000
Retained earnings		(155,000)				(155,000)
Correction of Amortizable Asset and Related Liability, Cumulative Net Impact [Member]
Assets related to discontinued operations		(50,000)				(50,000)
Liabilities related to discontinued operations
Additional paid-in capital		552,000				552,000
Retained earnings		(597,000)				(597,000)
Correction of Other Transactions, Impact from September 30, 2016 10K/A Filing [Member]
Assets related to discontinued operations		45,000				45,000
Other liabilities		269,000				269,000
Retained earnings		(137,000)				(137,000)
Additional paid in capital		8,000				8,000
Correction of Other Transactions, Current Period Impact [Member]
Assets related to discontinued operations
Other liabilities		(269,000)				(269,000)
Retained earnings		270,000				270,000
Additional paid in capital
Correction of Other Transactions, Cumulative Net Impact [Member]
Assets related to discontinued operations		45,000				45,000
Other liabilities
Retained earnings		133,000				133,000
Additional paid in capital		8,000				8,000
Previously Reported [Member]
Cash and cash equivalents		15,315,000				15,315,000
Restricted cash		34,748,000				34,748,000
Available for sale investments (at fair value)		5,500,000				5,500,000
Consumer receivables acquired for liquidation (at net realizable value)		9,118,000				9,118,000
Investment in personal injury claims, net		27,538,000				27,538,000
Due from third party collection agencies and attorneys		1,367,000				1,367,000
Prepaid and income taxes receivable		4,836,000				4,836,000
Furniture and equipment, net		141,000				141,000
Equity method investment
Deferred income taxes		18,940,000				18,940,000
Goodwill		1,410,000				1,410,000
Other assets		3,576,000				3,576,000
Assets related to discontinued operations		93,723,000				93,723,000
Total assets		216,212,000				216,212,000
Line of credit		9,600,000				9,600,000
Other liabilities		6,079,000				6,079,000
Liabilities related to discontinued operations		78,628,000				78,628,000
Total liabilities		94,307,000				94,307,000
Commitments and contingencies
Preferred stock
Common stock		134,000				134,000
Additional paid-in capital		67,467,000				67,467,000
Retained earnings		122,669,000				122,669,000
Accumulated other comprehensive income		(968,000)				(968,000)
Treasury stock (at cost)		(67,128,000)				(67,128,000)
Non-controlling interest		(269,000)				(269,000)
Total stockholders’ equity		121,905,000				121,905,000
Total liabilities and stockholders’ equity		216,212,000				216,212,000
Finance income recognized		3,980,000				11,999,000
Personal injury claims income		5,569,000				10,017,000
Disability fee income		1,134,000				3,990,000
Total revenues		10,683,000				26,006,000
Other Nonoperating Income		84,000
Revenues, Total		10,767,000				25,932,000
General and administrative		7,252,000				31,354,000
Interest		133,000				169,000
Impairment of consumer receivables		148,000				148,000
Loss (earnings) from equity method investment
		7,533,000				31,671,000
Income (loss) from continuing operations before income tax		3,234,000				(5,739,000)
Income Tax Expense (Benefit), Total		1,198,000				(2,170,000)
Net income (loss) from continuing operations		2,036,000				(3,569,000)
Net income (loss) from discontinued operations, net of income tax		526,000				(1,083,000)
Net Income (Loss) Attributable to Noncontrolling Interest, Total		730,000				742,000
Net income (loss)		$ 1,832,000				$ (5,394,000)
Continuing operations (in dollars per share)		$ 0.20
Discontinued operations (in dollars per share)		0.08
Basic, per share amount (in dollars per share)		0.28
Continuing operations (in dollars per share)		0.19				$ (0.46)
Discontinued operations (in dollars per share)		0.08				(0.11)
Diluted, per share amount (in dollars per share)		$ 0.27				$ (0.57)
Other income						$ (74,000)
Net (loss) income from continuing operations		$ 2,036,000				(3,569,000)
Net loss attributable to Asta Funding, Inc.		$ 1,832,000				$ (5,394,000)
Continuing operations (in dollars per share)						$ (0.46)
Discontinued operations (in dollars per share)						(0.11)
(in dollars per share)						(0.57)
(in dollars per share)		$ 0.27				$ (0.57)
Change in unrealized (losses) gains on marketable securities, net of tax benefit/ (expense)		$ 18,000				$ (17,000)
Amount reclassified from other comprehensive (loss) income		(11,000)				(607,000)
Foreign currency translation, net		(249,000)				(430,000)
Other comprehensive (loss) income		(242,000)				(1,054,000)
Total comprehensive income		1,590,000				(6,448,000)
Depreciation and Amortization						154,000
Deferred income taxes						(2,994,000)
Stock based compensation						81,000
Loss on sale of available-for-sale securities						1,011,000
Unrealized gain on other investments						3,590,000
Earnings from equity method investment
Forgiveness of debt
Prepaid and income taxes receivable						(3,956,000)
Due from third party collection agencies and attorneys						(362,000)
Other assets						3,050,000
Income tax payable						(252,000)
Other liabilities						1,083,000
Non-controlling interest						742,000
Net cash used in operating activities of discontinued operations						(3,654,000)
Net cash (used in) provided by operating activities						(6,753,000)
Purchase of consumer receivables acquired for liquidation						(2,213,000)
Principal collected on receivables acquired for liquidation						6,618,000
Purchase of available-for-sale securities						(13,193,000)
Proceeds from sale of available-for-sale securities						62,406,000
(Increase) decrease in equity method investment
Investments in personal injury claims — advances						(14,624,000)
Investments in personal injury claims — receipts						35,375,000
Capital expenditures						(19,000)
Net cash provided by (used in) investing activities of discontinued operations						1,548,000
Net cash provided by (used in) investing activities						75,898,000
Purchase of treasury stock						(54,203,000)
Distributions to non-controlling interest						(366,000)
Borrowings from line of credit						9,600,000
Net cash provided by financing activities of discontinued operations						9,000,000
Net cash (used in) provided by financing activities						(35,969,000)
Foreign currency effect on cash
Net increase in cash, cash equivalents and restricted cash including cash, cash equivalents classified within assets related to discontinued operations						33,176,000
Less: net decrease in cash, cash equivalents and restricted cash classified within assets related to discontinued operations						58,000
Net increase (decrease) in cash, cash equivalents and restricted cash						33,234,000
Cash, cash equivalents and restricted cash at beginning of period						16,829,000
Cash, cash equivalents and restricted cash at end of period		50,063,000				50,063,000				16,829,000
Restatement Adjustment [Member]
Impairment of consumer receivables
Loss (earnings) from equity method investment	[2]					(2,759,000)
Net income (loss) from continuing operations						(2,722,000)
Net income (loss) from discontinued operations, net of income tax						(673,000)
Net income (loss)						(3,395,000)
Net (loss) income from continuing operations						(2,722,000)
Net loss attributable to Asta Funding, Inc.						(3,395,000)
Depreciation and Amortization						(79,000)
Deferred income taxes	[3],[4]					4,193,000
Stock based compensation
Loss on sale of available-for-sale securities
Unrealized gain on other investments
Earnings from equity method investment	[2]					(2,759,000)
Forgiveness of debt	[5]					552,000
Prepaid and income taxes receivable	[3],[5]					(2,066,000)
Due from third party collection agencies and attorneys	[4]					42,000
Other assets	[4]					134,000
Income tax payable	[6]					252,000
Other liabilities	[4]					211,000
Non-controlling interest	[7]					(742,000)
Net cash used in operating activities of discontinued operations	[5],[6]					613,000
Net cash (used in) provided by operating activities						(3,044,000)
Purchase of consumer receivables acquired for liquidation
Principal collected on receivables acquired for liquidation	[4]					(294,000)
Purchase of available-for-sale securities
Proceeds from sale of available-for-sale securities
(Increase) decrease in equity method investment	[5],[6]					2,808,000
Investments in personal injury claims — advances	[7]					11,273,000
Investments in personal injury claims — receipts	[7]					(35,375,000)
Capital expenditures
Net cash provided by (used in) investing activities of discontinued operations
Net cash provided by (used in) investing activities						(21,588,000)
Purchase of treasury stock
Distributions to non-controlling interest	[7]					366,000
Borrowings from line of credit
Net cash provided by financing activities of discontinued operations
Net cash (used in) provided by financing activities						366,000
Foreign currency effect on cash	[4]					(37,000)
Net increase in cash, cash equivalents and restricted cash including cash, cash equivalents classified within assets related to discontinued operations						(24,303,000)
Less: net decrease in cash, cash equivalents and restricted cash classified within assets related to discontinued operations
Net increase (decrease) in cash, cash equivalents and restricted cash	[2],[3],[4],[5],[6],[7],[8]					(24,303,000)
Cash, cash equivalents and restricted cash at beginning of period						(547,000)
Cash, cash equivalents and restricted cash at end of period		(24,850,000)				(24,850,000)				$ (547,000)
Restatement Adjustment [Member] | Accounting For Investment in Pegasus Under The Equity Method [Member]
Cash and cash equivalents	[7]	(81,000)				(81,000)
Restricted cash	[7]	(24,748,000)				(24,748,000)
Available for sale investments (at fair value)	[7]
Consumer receivables acquired for liquidation (at net realizable value)	[7]
Investment in personal injury claims, net		(24,187,000)	[7]			(24,187,000)	[7]				$ (24,187,000)
Due from third party collection agencies and attorneys	[7]
Prepaid and income taxes receivable	[7]
Furniture and equipment, net	[7]
Equity method investment	[7]	48,639,000				48,639,000
Deferred income taxes	[7]
Goodwill	[7]
Other assets		(109,000)	[7]			(109,000)	[7]				(109,000)
Assets related to discontinued operations	[7]
Total assets	[7]	(486,000)				(486,000)
Line of credit	[7]
Other liabilities		(755,000)	[7]			(755,000)	[7]				(755,000)
Liabilities related to discontinued operations	[7]
Total liabilities	[7]	(755,000)				(755,000)
Commitments and contingencies	[7]
Preferred stock	[7]
Common stock	[7]
Additional paid-in capital	[7]
Retained earnings	[7]
Accumulated other comprehensive income	[7]
Treasury stock (at cost)	[7]
Non-controlling interest		269,000	[7]			269,000	[7]				$ 269,000
Total stockholders’ equity	[7]	269,000				269,000
Total liabilities and stockholders’ equity	[7]	(486,000)				(486,000)
Finance income recognized	[7]
Personal injury claims income	[7]	(5,328,000)				(9,766,000)
Disability fee income	[7]
Total revenues	[7]	(5,328,000)				(9,766,000)
Other Nonoperating Income	[7]
Revenues, Total	[7]	(5,328,000)				(9,766,000)
General and administrative		(1,681,000)				(6,058,000)
Interest	[7]	(2,000)				(6,000)
Impairment of consumer receivables	[7]
Loss (earnings) from equity method investment	[7]	(2,917,000)				(2,966,000)
	[7]	(4,598,000)				(9,024,000)
Income (loss) from continuing operations before income tax	[7]	(730,000)				(742,000)
Income Tax Expense (Benefit), Total	[7]
Net income (loss) from continuing operations	[7]	(730,000)				(742,000)
Net income (loss) from discontinued operations, net of income tax	[7]
Net Income (Loss) Attributable to Noncontrolling Interest, Total	[7]	(730,000)				(742,000)
Net income (loss)	[7]
Other income	[7]
Net (loss) income from continuing operations	[7]	(730,000)				(742,000)
Net loss attributable to Asta Funding, Inc.	[7]
Change in unrealized (losses) gains on marketable securities, net of tax benefit/ (expense)	[7]
Amount reclassified from other comprehensive (loss) income	[7]
Foreign currency translation, net	[7]
Other comprehensive (loss) income	[7]
Total comprehensive income	[7]
Earnings from equity method investment	[7]	(2,917,000)				(2,966,000)
Restatement Adjustment [Member] | All Corrections Not Related to Pegasus [Member]
Cash and cash equivalents	[4]	(21,000)				(21,000)
Restricted cash
Available for sale investments (at fair value)
Consumer receivables acquired for liquidation (at net realizable value)	[4]	92,000				92,000
Investment in personal injury claims, net
Due from third party collection agencies and attorneys	[4]	(10,000)				(10,000)
Prepaid and income taxes receivable	[3],[5]	1,900,000				1,900,000
Furniture and equipment, net
Equity method investment	[2]	(106,000)				(106,000)
Deferred income taxes	[3],[4]	(4,820,000)				(4,820,000)
Goodwill
Other assets	[4]	(59,000)				(59,000)
Assets related to discontinued operations	[5],[6]	(31,000)				(31,000)
Total assets		(3,055,000)				(3,055,000)
Line of credit
Other liabilities	[4]	(75,000)				(75,000)
Liabilities related to discontinued operations	[8]	1,000				1,000
Total liabilities		(74,000)				(74,000)
Commitments and contingencies
Preferred stock
Common stock
Additional paid-in capital	[5],[6]	560,000				560,000
Retained earnings	[2],[4],[5],[6],[8],[9]	(4,720,000)				(4,720,000)
Accumulated other comprehensive income	[4]	1,179,000				1,179,000
Treasury stock (at cost)
Non-controlling interest
Total stockholders’ equity		(2,981,000)				(2,981,000)
Total liabilities and stockholders’ equity		(3,055,000)				(3,055,000)
Finance income recognized	[4]	13,000				19,000
Personal injury claims income
Disability fee income
Total revenues		13,000				19,000
Other Nonoperating Income	[4]	6,000
Revenues, Total		19,000				(33,000)
General and administrative	[4],[6]	493,000				309,000
Interest	[4]	33,000				34,000
Impairment of consumer receivables
Loss (earnings) from equity method investment	[2]	207,000				207,000
		733,000				550,000
Income (loss) from continuing operations before income tax		(714,000)				(583,000)
Income Tax Expense (Benefit), Total	[3]	(979,000)				2,139,000
Net income (loss) from continuing operations		265,000				(2,722,000)
Net income (loss) from discontinued operations, net of income tax	[3],[5],[9]	34,000				(673,000)
Net Income (Loss) Attributable to Noncontrolling Interest, Total
Net income (loss)		299,000				(3,395,000)
Other income	[4]					(52,000)
Net (loss) income from continuing operations		265,000				(2,722,000)
Net loss attributable to Asta Funding, Inc.		299,000				(3,395,000)
Change in unrealized (losses) gains on marketable securities, net of tax benefit/ (expense)
Amount reclassified from other comprehensive (loss) income
Foreign currency translation, net	[4]	284,000				462,000	[6]
Other comprehensive (loss) income		284,000				462,000
Total comprehensive income		583,000				(2,933,000)
Earnings from equity method investment	[2]	$ 207,000				$ 207,000
[1]	Includes other amounts in other line items on the consolidated balance sheet.
[2]	The Company identified the personal injury claims asset balance of Pegasus was determined to be overstated at March 31, 2017 by $400,000. The correction of this error resulted in a decrease in earnings from the equity investment in Pegasus and income from continuing operations of $0 and $320,000 for the three and nine months ended June 30, 2017. Additionally, the equity investment was increased $101,000 to reflect the impact of the related accruals in the September 30, 2016 Form 10-K/A. During the three and nine months ended June 30, 2017, earnings from equity method investment decreased by $207,000 for a reduction in personal injury claims in Pegasus.
[3]	Some of the corrections noted above impacted earnings (loss) before taxes which, in turn, required a calculation of the tax impact. The net impact to the Company's consolidated balance sheet was an (i) increase to prepaid and income taxes receivable of $1,875,000; and (ii) decrease to deferred tax assets of $3,627,000. On the Company's consolidated statement of operations, there was (i) a net (decrease) to income tax expense of ($979,000); and (ii) a (decrease) to income tax benefit from discontinued operations of $(93,000) for the three months ended June 30, 2017. On the Company's consolidated statement of operations, there was (i) a net increase to income tax expense of $2,139,000; and (ii) an increase to income tax benefit from discontinued operations of $233,000 for the nine months ended June 30, 2017.
[4]	The Company determined that it had not previously accounted for certain foreign currency gains/losses on intercompany balances and transactions in accordance with US GAAP. The Company improperly accounted for the foreign currency effect of certain transactions as if they were long-term investments by including the foreign currency effect in accumulated other comprehensive income instead of properly recording the effect as operating expenses as required under ASC 830. The correction to properly apply U.S. GAAP to these foreign currency matters resulted in increased revenue of $13,000, an increase in other income of $6,000, an increase in general and administrative expenses of $493,000 and an increase in interest expense of $34,000 for the three months ended June 30, 2017. The correction to properly apply U.S. GAAP to these foreign currency matters resulted in increased revenue of $19,000, a decrease in other income of $52,000, and an increase in general and administrative expenses of $580,000, and an increase in interest expense of $34,000 for the nine months ended June 30, 2017.
[5]	The Company discovered that it did not properly record an amortizable asset and related liability in conjunction with an asset purchase agreement entered into in June 2015 with a related party. The correction of this error resulted in a decrease in income from discontinued operations of $34,000 and $153,000 for the three and nine months ended June 30, 2017.
[6]	The Company identified other transactions that had not been properly accounted for in the correct period and/or for improper amounts and/or improper accounts. The adjustments of these errors were immaterial on an individual basis. The correction of these errors resulted in decreased general and administrative expense of $0 and $271,000 for the three and nine months ended June 30, 2017.
[7]	In connection with the Company determining it lacked the requisite control to consolidate Pegasus during the Non-Reliance Period, the Company has now accounted for its investment in Pegasus under the equity method in accordance with US GAAP. On the Company's June 30, 2017 consolidated balance sheet, this resulted in (i) a decrease in cash and restricted cash of $24,829,000; (ii) a decrease in the investment in personal injury claims of $24,187,000; (iii) a decrease in other assets of $109,000; (iv) a decrease in other liabilities of $755,000; and (v) a decrease in non-controlling interest of $269,000, offset by a corresponding increase in the equity method investment of $48,639,000. On the Company's consolidated statement of operations, this resulted in (i) a decrease in total revenues of $5,328,000; (ii) a decrease in expenses of $1,681,000; (iii) a decrease in the income attributable to the non-controlling interest of $730,000; and (iv) a decrease in earnings from equity method investment of $2,917,000 the three months ended June 30, 2017. This change to the equity method of accounting had no effect on net (loss) income attributable to Asta Funding, Inc. during the Non-Reliance Period. On the Company's consolidated statement of operations, this resulted in (i) a decrease in total revenues of $9,766,000; (ii) a decrease in expenses of $6,058,000; (iii) a decrease in the income attributable to the non-controlling interest of $742,000; and (iv) a decrease in earnings from equity method investment of $2,966,000 the nine months ended June 30, 2017. This change to the equity method of accounting had no effect on net (loss) income attributable to Asta Funding, Inc. during the Non-Reliance Period.
[8]	The Company determined that it had not accounted for certain unallocated payments reported on its consolidated balance sheet properly during the Non-Reliance Period. The correction of this error resulted in a decrease to consumer receivables acquired for liquidation of $648,000 and retained earnings of $648,000 as of September 30, 2016 and is therefore included in the net adjustment to retained earnings as of June 30, 2017.
[9]	Prior to the sale of its structured settlement business, the Company purchased periodic payments under structured settlements and annuity policies from individuals in exchange for a lump sum payment. The Company has elected to carry the structured settlements at fair value in accordance with the guidance of FASB ASC, Recognition and Measurement of Financial Assets and Financial Liabilities (ASC 822-10-50-28 through 50-22). As previously disclosed in the Restated Form 10-Q/A, the Company did not reflect the quarterly increase in certain underlying benchmark interest rates used in determining fair value of the Company's structured settlements for the quarter ended December 31, 2016 which resulted in a decrease in the fair value of the Company's structured settlements of approximately $2.6 million (reflected in assets related to discontinued operations in this restated consolidated balance sheet) with an associated increase in prepaid income taxes and deferred tax assets of approximately $1.0 million (reflected in the loss from discontinued operations in this consolidated statement of operations). In connection with the Company's filing of the Form 10-K/A, the Company adjusted the fair value of its structured settlements to reflect the appropriate benchmark interest rates at September 30, 2016, which resulted in an decrease in net loss attributable to discontinued operations and an increase in assets related to discontinued operations of $727,000. As this increase in fair value was originally recorded during the three month period ended December 31, 2016, this Amendment includes an increase in both the retained earnings and the net loss attributable to discontinued operations of $727,000 as of and for the nine months ended June 30, 2017.

Note 2 - Business and Basis o45

Note 2 - Business and Basis of Presentation (Details Textual) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Sep. 30, 2016	Nov. 08, 2016	Sep. 30, 2015	Dec. 31, 2013	Dec. 28, 2011
Cash, Uninsured Amount	$ 9,800,000		$ 9,800,000
Cash, Uninsured Amount, Foreign	2,200,000		2,200,000
Restricted Cash, Total	10,000,000		10,000,000		$ 10,000,000
Disposal Group, Including Discontinued Operation, Restricted Cash	$ 500,000		$ 500,000
International Consumer Debt Portfolios, Percentage of Ownership	80.00%		80.00%
Equity Method Investments	$ 48,533,000		$ 48,533,000		48,582,000
Income (Loss) from Equity Method Investments, Total	2,710,000	$ 6,193,000	2,759,000	$ 6,193,000
Equity Method Investment, Other than Temporary Impairment	0	0	0	0
Goodwill, Ending Balance	$ 1,410,000		$ 1,410,000		1,410,000
Serlefin BPO&O Peru S.A.C. [Member]
Equity Method Investment, Ownership Percentage	49.00%		49.00%
Equity Method Investment, Ownership Percentage, Controlled Party	51.00%		51.00%
CBC [Member]
Equity Method Investment, Ownership Percentage	100.00%		100.00%					80.00%
Goodwill, Ending Balance	$ 1,400,000		$ 1,400,000
VATIV [Member]
Goodwill, Ending Balance	$ 1,400,000		$ 1,400,000
Pegasus Legal Funding LLC [Member]
Equity Method Investment, Percentage of Controlled Equity	50.00%		50.00%
Equity Method Investment, Ownership Percentage	80.00%		80.00%			80.00%			80.00%
Equity Method Investment, Ownership Percentage, Controlled Party						20.00%
Equity Method Investments	$ 48,533,000	48,582,000	$ 48,533,000	48,582,000	48,582,000		$ 40,751,000
Income (Loss) from Equity Method Investments, Total			2,759,000		10,551,000
Serlefin BPO&O Peru S.A.C. [Member]
Equity Method Investments	200,000		200,000		$ 200,000
Income (Loss) from Equity Method Investments, Total			$ 100,000
Pegasus Legal Funding LLC [Member]
Subsidiary of Limited Liability Company or Limited Partnership, Ownership Interest			80.00%
Restricted Cash, Total	$ 24,700,000		$ 24,700,000
Serlefin BPO&O Peru S.A.C. [Member]
International Consumer Debt Portfolios, Percentage of Ownership	20.00%		20.00%
Proceeds from International Consumer Debt Portfolios for Performance Fee	$ 115,000	$ 400,000	$ 94,000	$ 200,000

Note 3 - Available-for-sale I46

Note 3 - Available-for-sale Investments (Details Textual)	3 Months Ended		9 Months Ended
	Jun. 30, 2017USD ($)	Jun. 30, 2016USD ($)	Jun. 30, 2017USD ($)	Jun. 30, 2016USD ($)
Number of Investments Sold	3	1	6	3
Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments, Total	$ (18,000)	$ (32,000)	$ (1,011,000)	$ (63,000)
Realized Investment Gains (Losses), Total			177,000	47,000
Available-for-sale Securities, Gross Realized Gain (Loss), Total			$ (834,000)	$ (16,000)
Number of Investments	1		1

Note 3 - Available-for-sale I47

Note 3 - Available-for-sale Investments - Investments Classified as Available-for-sale (Details) - USD ($)	Jun. 30, 2017	Sep. 30, 2016
Amortized Cost	$ 5,500,000	$ 55,724,000
Unrealized Gains		1,088,000
Unrealized Losses		(49,000)
Fair Value	$ 5,500,000	$ 56,763,000

Note 4 - Consumer Receivables48

Note 4 - Consumer Receivables Acquired for Liquidation (Details Textual) - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended
	Dec. 31, 2007	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Sep. 30, 2016
Face Value of Charged-off Consumer Receivables		$ 0	$ 2,200,000	$ 35,000,000	$ 123,200,000
Purchased Cost of Charged-off Consumer Receivables		0	300,000	2,200,000	6,500,000
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities, Carrying Amount, Net		$ 9,210,000	$ 14,500,000	$ 9,210,000	$ 14,500,000	$ 13,427,000
Foreign Consumer Receivables, Percentage of Total Consumer Receivable		84.80%	55.20%	84.80%	55.20%
Fee Charged on Portfolio Purchase	3.00%
PERU
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities, Carrying Amount, Net		$ 4,500,000	$ 4,000,000	$ 4,500,000	$ 4,000,000
COLOMBIA
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities, Carrying Amount, Net		3,300,000	4,000,000	3,300,000	4,000,000
Non-US [Member]
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities, Carrying Amount, Net		$ 7,800,000	$ 8,000,000	$ 7,800,000	$ 8,000,000

Note 4 - Consumer Receivables49

Note 4 - Consumer Receivables Acquired for Liquidation - Changes In Balance Sheet Account of Consumer Receivables Acquired for Liquidation (Details) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Balance	$ 11,590,000	$ 16,440,000	$ 13,427,000	$ 15,056,000
Acquisitions of receivable portfolio		751,000	2,213,000	6,936,000
Net cash collections from collection of consumer receivables acquired for liquidation	(6,061,000)	(7,286,000)	(18,148,000)	(22,060,000)
Net cash collections represented by account sales of consumer receivables acquired for liquidation	(1,000)	(83,000)	(191,000)	(83,000)
Impairment	(148,000)		(148,000)	(124,000)
Effect of foreign currency translation	(163,000)	92,000	39,000	205,000
Finance income recognized	3,993,000	4,572,000	12,018,000	14,557,000
Balance	$ 9,210,000	$ 14,485,000	$ 9,210,000	$ 14,485,000
Finance income as a percentage of collections	65.90%	62.00%	65.50%	65.70%

Note 4 - Consumer Receivables50

Note 4 - Consumer Receivables Acquired for Liquidation - Collections Received Less Commissions and Direct Costs (Details) - USD ($)		3 Months Ended		9 Months Ended
		Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Gross collections (1)	[1]	$ 10,659,000	$ 12,380,000	$ 32,641,000	$ 36,982,000
Commissions and fees (2)	[2]	4,597,000	5,011,000	14,302,000	14,839,000
Net collections		$ 6,062,000	$ 7,369,000	$ 18,339,000	$ 22,143,000
[1]	Gross collections include: collections from third-party collection agencies and attorneys, collections from in-house efforts, and collections represented by account sales.
[2]	Commissions are earned by third party collection agencies and attorneys, and include direct costs associated with the collection effort, generally court costs. In December 2007 an arrangement was consummated with one servicer who also received a 3% fee on gross collections received by the Company in connection with the related portfolio purchase. The fee is charged for asset location, skip tracing and ultimately suing debtors in connection with this portfolio purchase.

Note 5 - Litigation Funding (De

Note 5 - Litigation Funding (Details Textual) - USD ($)	May 18, 2012	May 08, 2012	Jun. 30, 2017	Jun. 30, 2016	Mar. 31, 2017	Jun. 30, 2017	Jun. 30, 2016	Sep. 30, 2016	Jan. 12, 2018	Nov. 08, 2016	Sep. 30, 2015	Sep. 30, 2014	May 02, 2014	Dec. 28, 2011
Company Investment in Personal Injury						$ 48,500,000		$ 48,600,000
Equity Method Investments			$ 48,533,000			48,533,000		48,582,000
Income (Loss) from Equity Method Investments, Total			2,710,000	$ 6,193,000		2,759,000	$ 6,193,000
Restricted Cash, Total			10,000,000			10,000,000		10,000,000
Line of Credit Facility, Maximum Borrowing Capacity													$ 30,000,000
Valuation Allowances and Reserves, Other						1,700,000
Net Investment Income, Total						0	0
Provision for Loan and Lease Losses, Total			700,000
Revolving Credit Facility [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 1,000,000											$ 1,500,000
Debt Instrument, Term	2 years
Line of Credit Facility, Write-off					$ 1,500,000
Pegasus Legal Funding LLC [Member]
Earnings in Interest and Fees from Invested Venture			5,100,000	9,800,000		9,800,000	14,800,000
Restricted Cash, Total			$ 24,700,000			$ 24,700,000
Subsidiary of Limited Liability Company or Limited Partnership, Ownership Interest						80.00%
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners									20.00%	20.00%
BP Case Management, LLC [Member]
Subsidiary of Limited Liability Company or Limited Partnership, Ownership Interest		60.00%
Balance Point Divorce Funding, LLC [Member]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners		40.00%
Pegasus Legal Funding LLC [Member]
Equity Method Investment, Ownership Percentage			80.00%			80.00%				80.00%				80.00%
Equity Method Investments			$ 48,533,000	$ 48,582,000		$ 48,533,000	$ 48,582,000	48,582,000			$ 40,751,000
Income (Loss) from Equity Method Investments, Net of Dividends or Distributions, Total						(49,000)		7,831,000
Income (Loss) from Equity Method Investments, Total						2,759,000		10,551,000
Payments to Acquire Equity Method Investments						$ 2,808,000		$ 2,720,000
Equity Method Investment, Ownership Percentage, Controlled Party										20.00%

Note 5 - Litigation Funding - E

Note 5 - Litigation Funding - Equity Method Investments (Details) - USD ($)	Jun. 30, 2017	Sep. 30, 2016
Equity Method Investments	$ 48,533,000	$ 48,582,000
Pegasus Funding LLC [Member]
Equity Method Investments	$ 48,533,000	$ 48,582,000
Equity Method Investment, Ownership Percentage	80.00%	80.00%

Note 5 - Litigation Funding -53

Note 5 - Litigation Funding - Equity Method Investments Financial Statements (Details) - USD ($)	3 Months Ended			9 Months Ended
	Jun. 30, 2017		Jun. 30, 2016	Jun. 30, 2017		Jun. 30, 2016	Sep. 30, 2016
Pegasus Legal Funding LLC [Member]
Personal injury claims income	$ 5,068,000		$ 9,838,000	$ 9,507,000		$ 14,769,000
Operating expenses	1,680,000		2,096,000	6,058,000		4,744,000
Income from operations	3,388,000		7,742,000	3,449,000		10,025,000
Earnings from equity investment	2,710,000		6,193,000	2,759,000		8,020,000
Company’s equity income from operations	2,710,000		$ 6,193,000	2,759,000		$ 8,020,000
Pegasus Funding LLC [Member]
Cash	24,829,000	[1]		24,829,000	[1]		$ 539,000
Investment in personal injury claims	23,927,000			23,927,000			48,289,000
Other assets	109,000			109,000			188,000
Total assets	48,865,000			48,865,000			49,016,000
Due to Asta	31,596,000			31,596,000			34,404,000
Other liabilities	628,000			628,000			1,053,000
Equity	16,641,000			16,641,000			13,559,000
Total liabilities and equity	$ 48,865,000			$ 48,865,000			$ 49,016,000
[1]	Included in current assets is $24.7 million in restricted cash. The restriction has been put in place during the Company’s arbitration with PLF, see Note 20 – Subsequent Events.

Note 6 - Furniture & Equipmen54

Note 6 - Furniture & Equipment - Summary of Furniture and Equipment (Details) - USD ($)	Jun. 30, 2017	Sep. 30, 2016
Total	$ 1,878,000	$ 1,858,000
Less accumulated depreciation and amortization	1,737,000	1,662,000
Balance, end of period	141,000	196,000
Furniture and Fixtures [Member]
Total	273,000	273,000
Equipment [Member]
Total	242,000	235,000
Software Development [Member]
Total	$ 1,363,000	$ 1,350,000

Note 7 - Non Recourse Debt (Det

Note 7 - Non Recourse Debt (Details Textual) - USD ($)	Aug. 02, 2017	Mar. 30, 2016	Jun. 03, 2014	May 02, 2014	Aug. 07, 2013	Jun. 30, 2016	Mar. 31, 2007	Jun. 30, 2017	Sep. 30, 2016
Portfolio Purchase							$ 300,000,000
Receivables Financing Agreement Term							3 years
Percentage of Ownership in Subsidiaries					100.00%
Prepayment Fees					$ 15,000,000
Receivable Finance Agreement, Portfolio Purchase Collections, Percentage					30.00%
Debt Instrument, Final Principal Payment			$ 2,901,000
Voluntary Debt Prepayment			1,866,000
Receivable Finance Agreement, Collections from Portfolio Purchase			$ 16,900,000			$ 16,900,000
Line of Credit Facility, Current Borrowing Capacity				$ 20,000,000
Line of Credit Facility, Maximum Borrowing Capacity				$ 30,000,000
Line of Credit Facility, Expiration Period				3 years
Debt Instrument, Basis Spread on Variable Rate				2.75%
Line of Credit Facility, Covenant Consolidated Tangible Net Worth				$ 150,000,000
Long-term Line of Credit, Total								$ 9,600,000
Amended Loan Agreement [Member]
Debt Instrument, Basis Spread on Variable Rate		2.25%
Line of Credit Facility, Covenant Consolidated Tangible Net Worth		$ 100,000,000
Line of Credit Facility, Covenant Decrease Consolidated Tangible Net Worth		$ 50,000,000
Long-term Line of Credit, Total								9,600,000
Repayments of Long-term Lines of Credit	$ 9,600,000
Bank of Montreal [Member]
Non-Recourse Debt								$ 164,000
Receivables Financing Agreement [Member]
Non-Recourse Debt							$ 227,000,000

Note 8 - Discontinued Operati56

Note 8 - Discontinued Operations (Details Textual) - USD ($)	Dec. 13, 2017	Jan. 01, 2016	Dec. 31, 2015	Mar. 01, 2015	Dec. 31, 2013	Jun. 30, 2017	Jun. 30, 2016	Sep. 29, 2014	Jun. 30, 2017	Jun. 30, 2016	Sep. 30, 2017	Apr. 07, 2017	Sep. 30, 2016	Jul. 08, 2016	Sep. 25, 2015	Nov. 26, 2014	May 02, 2014
Disposal Group, Including Discontinued Operation, Assets, Total						$ 93,692,000			$ 93,692,000				$ 91,506,000
Disposal Group, Including Discontinued Operation, Liabilities, Total						78,629,000			78,629,000				69,238,000
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent, Total						560,000	$ 577,000		(1,756,000)	$ 1,404,000
Cash, Uninsured Amount						9,800,000			9,800,000
Line of Credit Facility, Current Borrowing Capacity																	$ 20,000,000
Line of Credit Facility, Maximum Borrowing Capacity																	$ 30,000,000
Long-term Line of Credit, Total						9,600,000			9,600,000
CBC [Member]
Disposal Group, Including Discontinued Operation, Assets, Total						93,692,000			93,692,000				91,506,000
Disposal Group, Including Discontinued Operation, Liabilities, Total						78,629,000			78,629,000				$ 69,238,000
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent, Total						560,000	$ 577,000		(1,756,000)	$ 1,404,000
Cash, Uninsured Amount						800,000			800,000
Structured Settlements, Unrealized Gain (Losses)									4,500,000
Structured Settlements, Gain on New Structured Settlements Financed									5,900,000
Structured Settlements, Unrealized Gain (Loss), Decrease in Realized Gains Recognized as Realized Interest Income on Structured Settlements									100,000
Structured Settlements, Reduction in Fair Value									1,500,000
Gain (Loss) on Sale of Life contingent Asset Portfolio									(5,300,000)
CBC [Member] | Subsequent Event [Member]
Disposal Group, Including Discontinued Operation, Consideration	$ 10,500,000
Disposal Group, Including Discontinued Operation, Cash Consideration	4,490,000
Disposal Group, Including Discontinued Operation, Promissory Note Consideration	$ 5,750,000
Promissory Note Interest Rate, Discontinued Operations	7.00%
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax, Total											$ 1,900,000
Life Contingent Annuities Portfolio [Member]
Disposal Group, Including Discontinued Operation, Consideration						7,700,000			7,700,000
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax, Total						$ (5,400,000)			$ (5,400,000)
Restricted Stock [Member]
Shares Lock-up Period			1 year
CBC [Member]
Equity Method Investment, Ownership Percentage					80.00%	100.00%			100.00%
Business Combination, Consideration Transferred, Total			$ 1,800,000		$ 5,900,000
Business Acquisition, Percentage of Voting Interests Acquired			20.00%
Payments to Acquire Businesses, Gross			$ 800,000
Employment Agreement Term		2 years
Employee Agreement Renewal Term		1 year
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities, Total					25,900,000
Line of Credit Facility, Current Borrowing Capacity					$ 12,500,000
Debt Instrument, Floor Interest Rate				4.10%	5.50%			4.75%
Line of Credit Facility, Maximum Borrowing Capacity				$ 25,000,000				$ 22,000,000
Other Long-term Debt, Total						$ 76,400,000			$ 76,400,000
Long-term Line of Credit, Total						4,300,000			4,300,000
Notes Payable, Noncurrent, Total						$ 72,100,000			$ 72,100,000
CBC [Member] | Secured Debt [Member]
Debt Instrument, Face Amount												$ 18,300,000		$ 14,800,000	$ 16,600,000	$ 21,800,000
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate												5.00%		4.85%	5.10%	5.40%
CBC [Member] | Principal One [Member]
Payments to Acquire Businesses, Gross			400,000
CBC [Member] | Restricted Stock [Member]
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable			$ 1,000,000
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares			123,304
Shares Lock-up Period			1 year
CBC [Member] | Restricted Stock [Member] | Principal One [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares			61,652
Shares Issued, Price Per Share			$ 7.95

Note 8 - Discontinued Operati57

Note 8 - Discontinued Operations - Financial Statements (Details) - USD ($)	3 Months Ended			9 Months Ended
	Jun. 30, 2017		Jun. 30, 2016	Jun. 30, 2017		Jun. 30, 2016	Sep. 30, 2016
Income from discontinued operations, net of income tax	$ 560,000		$ 577,000	$ (1,756,000)		$ 1,404,000
Restricted cash	500,000			500,000
Total assets related to discontinued operations	93,692,000			93,692,000			$ 91,506,000
Total liabilities related to discontinued operations	78,629,000			78,629,000			69,238,000
CBC [Member]
Unrealized gain on structured settlements	7,531,000		1,422,000	4,511,000		4,586,000
Interest income on structured settlements	1,923,000		1,765,000	5,765,000,000		4,473,000
Loss on sale of structured settlements	(5,353,000)			(5,353,000)
Total revenues	4,101,000		3,187,000	4,923,000		9,059,000
Other income	14,000		46,000	44,000		46,000
	4,115,000		3,233,000	4,967,000		9,105,000
General and administrative expenses	2,156,000		1,406,000	5,152,000		4,157,000
Interest expense	990,000		833,000	2,871,000		2,349,000
	3,146,000		2,239,000	8,023,000		6,506,000
Income from discontinued operations before income tax	969,000		994,000	(3,056,000)		2,599,000
Income tax expense from discontinued operations	409,000		417,000	(1,300,000)		1,091,000
Income from discontinued operations, net of income tax	560,000		$ 577,000	(1,756,000)		1,404,000
(Loss) income from discontinued operations before non-controlling interest				(1,756,000)		1,508,000
Non-controlling interest						$ 104,000
Cash and cash equivalents	1,256,000	[1]		1,256,000	[1]		1,198,000
Restricted cash	499,000			499,000			499,000
Structured settlements	88,268,000			88,268,000			86,091,000
Furniture and equipment, net	37,000			37,000			47,000
Goodwill	1,405,000			1,405,000			1,405,000
Other assets	2,227,000			2,227,000			2,266,000
Total assets related to discontinued operations	93,692,000			93,692,000			91,506,000
Other debt - CBC	76,435,000			76,435,000			67,435,000
Other liabilities	2,194,000			2,194,000			1,803,000
Total liabilities related to discontinued operations	$ 78,629,000			$ 78,629,000			$ 69,238,000
[1]	Cash balance with one bank at June 30, 2017 that exceeded the balance insured by the FDIC by approximately $0.8 million.

Note 8 - Discontinued Operati58

Note 8 - Discontinued Operations - Components of Structured Settlements (Details) - USD ($)		Jun. 30, 2017	Sep. 30, 2016
Maturity (1) (2)	[1],[2]	$ 135,132,000	$ 133,059,000
Unearned income		(46,864,000)	(46,968,000)
Structured settlements, net		$ 88,268,000	$ 86,091,000
[1]	The maturity value represents the aggregate unpaid principal balance at June 30, 2017 and September 30, 2016.
[2]	There are no amounts of structured settlements that are past due, or in nonaccrual status at June 30, 2017 and September 30, 2016.

Note 8 - Discontinued Operati59

Note 8 - Discontinued Operations - Structured Settlements (Details) - USD ($)	Jun. 30, 2017	Sep. 30, 2016
Notes payable secured by settlement receivables with principal and interest outstanding payable, encumbered and unencumbered	$ 88,268,000	$ 86,091,000
Structured Settlement [Member]
Interest Rate	4.10%
Notes payable secured by settlement receivables with principal and interest outstanding payable, encumbered and unencumbered	$ 4,300,000	10,154,000
Structured Settlements Encumbered By Notes Payable Due June 2025 [Member]
Interest Rate	8.75%
Notes payable secured by settlement receivables with principal and interest outstanding payable, encumbered and unencumbered	$ 1,716,000	1,862,000
Structured Settlements Encumbered By Notes Payable Due August 2026 [Member]
Interest Rate	7.25%
Notes payable secured by settlement receivables with principal and interest outstanding payable, encumbered and unencumbered	$ 3,947,000	4,242,000
Structured Settlements Encumbered By Notes Payable Due April 2032 [Member]
Interest Rate	7.125%
Notes payable secured by settlement receivables with principal and interest outstanding payable, encumbered and unencumbered	$ 3,907,000	3,987,000
Structured Settlements Encumbered By Notes Payable Due February 2037 [Member]
Interest Rate	5.39%
Notes payable secured by settlement receivables with principal and interest outstanding payable, encumbered and unencumbered	$ 17,765,000	18,978,000
Structured Settlements Encumbered By Notes Payable Due March 2034 [Member]
Interest Rate	5.07%
Notes payable secured by settlement receivables with principal and interest outstanding payable, encumbered and unencumbered	$ 13,780,000	14,507,000
Structured Settlements Encumbered By Notes Payable Due February 2043 [Member]
Interest Rate	4.85%
Notes payable secured by settlement receivables with principal and interest outstanding payable, encumbered and unencumbered	$ 13,259,000	13,705,000
Structured Settlements Encumbered By Notes Payable Due January 2069 [Member]
Interest Rate	5.00%
Notes payable secured by settlement receivables with principal and interest outstanding payable, encumbered and unencumbered	$ 17,761,000
Structured Settlements Encumbered [Member]
Notes payable secured by settlement receivables with principal and interest outstanding payable, encumbered and unencumbered	76,435,000	67,435,000
Structured Settlements Not Encumbered [Member]
Notes payable secured by settlement receivables with principal and interest outstanding payable, encumbered and unencumbered	$ 11,833,000	$ 18,656,000

Note 8 - Discontinued Operati60

Note 8 - Discontinued Operations - Structured Settlements (Details) (Parentheticals) - USD ($)	Jun. 30, 2017	Sep. 30, 2016	May 02, 2014
Revolving line of credit, borrowing capacity			$ 30,000,000
Structured Settlement [Member]
Revolving line of credit, borrowing capacity	$ 25,000,000	$ 25,000,000

Note 8 - Discontinued Operati61

Note 8 - Discontinued Operations - Expected Cash Flows of Structured Settlements Based on Maturity Value (Details) - USD ($)		Jun. 30, 2017	Sep. 30, 2016
September 30, 2017 (3 months)		$ 2,679,000
September 30, 2018		9,020,000
September 30, 2019		9,312,000
September 30, 2020		8,989,000
September 30, 2021		9,474,000
Thereafter		95,658,000
Total	[1],[2]	$ 135,132,000	$ 133,059,000
[1]	The maturity value represents the aggregate unpaid principal balance at June 30, 2017 and September 30, 2016.
[2]	There are no amounts of structured settlements that are past due, or in nonaccrual status at June 30, 2017 and September 30, 2016.

Note 9 - Commitments and Cont62

Note 9 - Commitments and Contingencies (Details Textual) - USD ($)	Nov. 11, 2016	Jul. 24, 2015	Sep. 30, 2016	Mar. 31, 2016	Jun. 30, 2017	Jun. 30, 2016
Violation of Federal Fair Debt Collection Practice Act and Racketeer Influenced and Corrupt Organization Act [Member]
Litigation Settlement, Amount Awarded to Other Party		$ 39,000
Litigation Settlement, Amount Offered, Consideration						$ 3,900,000
Estimated Litigation Liability					$ 2,300,000
Violation of Federal Fair Debt Collection Practice Act and Racketeer Influenced and Corrupt Organization Act [Member] | General and Administrative Expense [Member]
Litigation Settlement, Expense			$ 300,000	$ 2,000,000
Violation of Federal Fair Debt Collection Practice Act and Racketeer Influenced and Corrupt Organization Act [Member] | Individual Basis for a Payment to each Plaintiff [Member]
Litigation Settlement, Amount Awarded to Other Party		$ 13,000
Chief Executive Officer [Member] | Simia Capital LLC [Member]
Employment Agreement, Annual Base Salary	$ 250,000
Employment Agreement, Profit Bonus, Percentage of Profit	15.00%
Employment Agreement, Profit Bonus, Minimum Internal Rate of Return	18.00%
Employment Agreement, Profit Bonus, Percentage of Closing Consideration	15.00%
Employment Agreement Term	5 years
Employment Agreement, Severance, Years of Base Salary	2 years
Term of Non-compete and Non-solicitation Provision	2 years

Note 10 - Income Recognition,63

Note 10 - Income Recognition, Impairments, and Commissions and Fees (Details Textual) - Fixed Income Funds [Member] - USD ($) $ in Millions	1 Months Ended	3 Months Ended	12 Months Ended
	Oct. 31, 2014	Mar. 31, 2017	Sep. 30, 2016
Available-for-sale Securities, Equity Securities	$ 5
Related Party Transaction, Rate	14.00%
Other than Temporary Impairment Losses, Investments, Total		$ 3.4	$ 1

Note 11 - Income Taxes (Details

Note 11 - Income Taxes (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Effective Income Tax Rate Reconciliation, Percent, Total	12.20%	34.80%	0.40%	33.70%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent				35.00%
Unrecognized Tax Benefits, Ending Balance	$ 0		$ 0

Note 12 - Net Income (Loss) P65

Note 12 - Net Income (Loss) Per Share (Details Textual) - $ / shares	3 Months Ended		9 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2016
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	942,067	56,007	186,082
Weighted Average Exercise Price	$ 8.15	$ 12.55	$ 10.88

Note 12 - Net (Loss) Income Per

Note 12 - Net (Loss) Income Per Share - Computation of Basic and Diluted Per Share Data (Details) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Net (loss) income from continuing operations	$ 1,571,000	$ 3,289,000	$ (7,033,000)	$ 2,195,000
Net (loss) income from continuing operations, weighted average shares (in shares)	6,577,784	11,897,139	9,389,864	12,023,156
Net (loss) income from continuing operations, per share amount (in dollars per share)	$ 0.24	$ 0.27	$ (0.75)	$ 0.18
Net income (loss) from discontinued operations, net of income tax	$ 560,000	$ 577,000	$ (1,756,000)	$ 1,404,000
Net (loss) income from discontinued operations, weighted average shares (in shares)	6,577,784	11,897,139	9,389,864	12,023,156
Net (loss) income from discontinued operations, per share amount (in dollars per share)	$ 0.08	$ 0.05	$ (0.19)	$ 0.12
Net income (loss)	$ 2,131,000	$ 3,866,000	$ (8,789,000)	$ 3,599,000
Basic, per share amount (in dollars per share)	$ 0.32	$ 0.32	$ (0.94)	$ 0.30
Effect of Dilutive Stock, weighted average shares (in shares)	301,298	536,285		270,917
Effect of Dilutive Stock (in dollars per share)	$ (0.01)	$ (0.01)		$ (0.01)
Diluted, weighted average shares (in shares)	6,879,082	12,433,424	9,389,864	12,294,073
Diluted, per share amount (in dollars per share)	$ 0.31	$ 0.31	$ (0.94)	$ 0.29

Note 13 - Stock Based Compens67

Note 13 - Stock Based Compensation (Details Textual) - shares	Jun. 08, 2017	Dec. 31, 2015	Dec. 16, 2015	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	56,600		67,100	56,600		56,600	67,100
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period		123,304	5,000				128,304	5,000
Shares Lock-up Period		1 year
Share-based Compensation Award, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares	10,000		9,100
Share-based Compensation Award, Tranche Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	10,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number			58,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period			3 years
Share-based Compensation Award, Tranche Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	10,000
Share-based Compensation Award, Tranche Four [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	26,600
Share-based Compensation Award, Tranche Four [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	3 years

Note 13 - Stock Based Compens68

Note 13 - Stock Based Compensation - Weighted Average Assumptions Used in Option Pricing Model (Details)	Jun. 08, 2017	Dec. 16, 2015
Risk-free interest rate	1.86%	0.24%
Expected term (years) (Year)	5 years 354 days	6 years 91 days
Expected volatility	26.27%	23.40%
Dividend yield	0.00%	0.00%
Forfeiture rate	3.49%

Note 14 - Stock Option Plans (D

Note 14 - Stock Option Plans (Details Textual)	Jun. 08, 2017shares	Dec. 31, 2015shares	Dec. 16, 2015shares	Jun. 30, 2017USD ($)shares	Jun. 30, 2016USD ($)shares	Jun. 30, 2017USD ($)shares	Jun. 30, 2016USD ($)shares	Jun. 30, 2015shares	Jun. 30, 2017USD ($)shares	May 05, 2012shares	Mar. 21, 2012shares	Mar. 01, 2006shares	May 01, 2002shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	56,600		67,100	56,600		56,600	67,100
Allocated Share-based Compensation Expense, Total | $				$ 30,000	$ 139,000	$ 38,000	$ 567,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Total | $				132,000		132,000			$ 132,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | $				$ 287,000	$ 208,000	$ 287,000	$ 208,000		287,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term						4 years 255 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period				0	100,032	0	107,531
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | $				$ 81,000	$ 120,000	$ 734,000	$ 1,368,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Total Fair Value | $				$ 371,000	$ 0	$ 371,000	$ 709,000
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period		123,304	5,000				128,304	5,000
Allocated Share-based Compensation Expense, Total | $				$ 0	$ 13,000	$ 0	$ 114,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value | $						0	326,000
Employee Stock Option [Member]
Allocated Share-based Compensation Expense, Total | $				30,000	$ 126,000	38,000	$ 453,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Total | $				$ 132,000		$ 132,000			$ 132,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition						2 years
The 2012 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized											2,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross									540,800
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period									67,868
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant				1,281,443		1,281,443			1,281,443
Share-based Compensation Arrangement by Share-based Payment Award, Number of Eligible Employees									88
The 2012 Plan [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period									245,625
Equity Compensation Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized												1,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant											0
The 2002 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized													1,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant										0

Note 14 - Stock Option Plans -

Note 14 - Stock Option Plans - Summary of Stock Option Plans (Details) - $ / shares	Jun. 08, 2017	Dec. 16, 2015	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Outstanding options at the beginning of period (in shares)			896,867	1,094,867	949,667	1,043,566
Outstanding options at the beginning of period (in dollars per share)			$ 8.14	$ 8.45	$ 8.47	$ 8.47
Options granted (in shares)	56,600	67,100	56,600		56,600	67,100
Options granted (in dollars per share)			$ 6.55		$ 6.55	$ 7.93
Options exercised (in shares)			0	(100,032)	0	(107,531)
Options exercised (in dollars per share)				$ 8.24		$ 8.11
Options forfeited/cancelled (in shares)			(1,000)		(53,800)	(8,300)
Options forfeited/cancelled (in dollars per share)			$ 7.93		$ 14.01	$ 8.14
Outstanding options at the end of period (in shares)			952,467	994,835	952,467	994,835
Outstanding options at the end of period (in dollars per share)			$ 8.05	$ 8.47	$ 8.05	$ 8.47
Options Exercisable, Number of Shares Exercisable (in shares)			867,195	874,826	867,195	874,826
Options Exercisable, Weighted Average Exercise Price (in dollars per share)			$ 8.13	$ 8.51	$ 8.13	$ 8.51

Note 14 - Stock Option Plans 71

Note 14 - Stock Option Plans - Summary of Outstanding Options (Details) - $ / shares	9 Months Ended
	Jun. 30, 2017	Mar. 31, 2017	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Sep. 30, 2015
Options Outstanding, Number of Shares Outstanding (in shares)	952,467	896,867	949,667	994,835	1,094,867	1,043,566
Options Outstanding, Weighted Average Remaining Contractual Life (Year)	5 years 36 days
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 8.05	$ 8.14	$ 8.47	$ 8.47	$ 8.45	$ 8.47
Options Exercisable, Number of Shares Exercisable (in shares)	867,195			874,826
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 8.13			$ 8.51
Range One [Member]
Range of Exercise Price, Lower (in dollars per share)	2.8751
Range of Exercise Price, Upper (in dollars per share)	$ 4.30
Options Outstanding, Number of Shares Outstanding (in shares)	3,800
Options Outstanding, Weighted Average Remaining Contractual Life (Year)	1 year 292 days
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 2.95
Options Exercisable, Number of Shares Exercisable (in shares)	3,800
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 2.95
Range Two [Member]
Range of Exercise Price, Lower (in dollars per share)	5.7501
Range of Exercise Price, Upper (in dollars per share)	$ 8.625
Options Outstanding, Number of Shares Outstanding (in shares)	824,167
Options Outstanding, Weighted Average Remaining Contractual Life (Year)	5 years 36 days
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 7.86
Options Exercisable, Number of Shares Exercisable (in shares)	738,895
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 7.94
Range Three [Member]
Range of Exercise Price, Lower (in dollars per share)	8.6251
Range of Exercise Price, Upper (in dollars per share)	$ 11.50
Options Outstanding, Number of Shares Outstanding (in shares)	124,500
Options Outstanding, Weighted Average Remaining Contractual Life (Year)	5 years 219 days
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 9.40
Options Exercisable, Number of Shares Exercisable (in shares)	124,500
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 9.40

Note 14 - Stock Option Plans 72

Note 14 - Stock Option Plans - Summary of Restricted Stock Transactions (Details) - Restricted Stock [Member] - $ / shares	Dec. 31, 2015	Dec. 16, 2015	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Unvested at the beginning of period (in shares)				138,304		44,107
Unvested at the beginning of period (in dollars per share)				$ 7.92		$ 9.28
Awards granted (in shares)	123,304	5,000				128,304	5,000
Awards granted (in dollars per share)						$ 7.89
Vested (in shares)				(5,000)		(39,107)
Vested (in dollars per share)						$ 9.57
Forfeited (in shares)
Forfeited (in dollars per share)
Unvested at the end of period (in shares)				133,304		133,304
Unvested at the end of period (in dollars per share)				$ 7.92		$ 7.92

Note 15 - Stockholders' Equity

Note 15 - Stockholders' Equity (Details Textual) - USD ($)

May 05, 2017

Mar. 10, 2017

Feb. 15, 2017

Feb. 06, 2017

Jan. 06, 2017

Nov. 21, 2016

Mar. 17, 2016

Jun. 30, 2017

Mar. 31, 2017

Jun. 30, 2016

Jun. 30, 2017

Jun. 30, 2016

Sep. 30, 2016

Jan. 18, 2017

Dec. 17, 2015

Aug. 11, 2015

Common Stock, Dividends, Per Share, Declared

$ 0

$ 0

$ 0

$ 0

Treasury Stock, Value, Acquired, Cost Method

$ 54,203,000

$ 11,174,000

Share Price

$ 10.20

Dividends, Rights Offered for Each Issued and Outstanding Share of Stock

1

Minimum Number of Days After Obtaining Beneficial Ownership Percentage for Rights to Become Exercisable

10 days

Minimum Beneficial Ownership Percentage of Common Stock Required for Rights to Become Exercisable

10.00%

Number of Days After Tender or Exchange Offer Resulting in New Ownership for Rights to Become Exercisable

10 days

Multiple Used to Determine Market Value

2

Rights, Redemption Price Per Share

$ 0.01

Number of Shares Common Stock Given in Exchange for One Right if Under New Ownership

1

Right [Member]

Class of Warrant or Right, Number of Securities Called by Each Warrant or Right

0.001

Right [Member] | Series A Junior Participating Preferred Stock [Member]

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 28.60

Mangrove [Member]

Mutual Confidentiality Agreement, Extended Period

30 days

Mangrove [Member] | Ricky Stern Family [Member]

Treasury Stock, Value, Acquired, Cost Method

$ 4,900,000

Treasury Stock, Shares, Acquired

471,086

Stern Stockholders [Member]

Voting Agreement, Related Party Maximum Percentage of Voting Right

49.00%

Shares Repurchase Plan [Member]

Stock Repurchase Program, Authorized Amount

$ 15,000,000

$ 15,000,000

Stock Repurchase Program, Additional Authorized Repurchase Amount

$ 15,000,000

Treasury Stock, Value, Acquired, Cost Method

$ 9,900,000

$ 10,100,000

Treasury Stock, Shares, Acquired

1,186,000

Settlement Agreement [Member]

Treasury Stock, Value, Acquired, Cost Method

$ 54,200,000

Stock Repurchase Program, Number of Shares Authorized to be Repurchased

5,314,009

Stock Repurchase Program, Purchase Price Per Share

$ 10.35

Stock Repurchase Program, Number of Share Tendered

6,022,253

Stock Repurchase Program, Number of Shares Oversubscribed

708,244

Stock Repurchase Program, Percent of Share Tendered

88.24%

Treasury Stock, Percent, Acquired

44.70%

Settlement Agreement [Member] | General and Administrative Expense [Member]

Treasury Stock, Value, Acquired, Cost Method

$ 797,000

Settlement Agreement [Member] | Mangrove [Member]

Stock Repurchase Program, Number of Shares Authorized to be Repurchased

4,005,701

Note 16 - Fair Value of Finan74

Note 16 - Fair Value of Financial Measurements and Disclosures (Details Textual) - USD ($)	9 Months Ended
	Jun. 30, 2017	Sep. 30, 2016
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Redemption Restriction Period	5 years
Available-for-sale Securities, Total	$ 5,500,000	$ 56,763,000
Fair Value, Inputs, Level 2 [Member]
Available-for-sale Securities, Total	0
Fair Value, Inputs, Level 3 [Member]
Available-for-sale Securities, Total	$ 0

Note 16 - Fair Value of Finan75

Note 16 - Fair Value of Financial Measurements and Disclosures - Fair Value of Financial Measurements (Details) - USD ($)	Jun. 30, 2017	Sep. 30, 2016
Fair Value	$ 5,500,000	$ 56,763,000
Fair Value, Inputs, Level 3 [Member]
Fair Value	0
Reported Value Measurement [Member] | Fair Value, Inputs, Level 1 [Member]
Cash equivalents (Level 1)	2,864,000	923,000
Fair Value	5,500,000	56,764,000
Other investments, net		3,590,000
Structured settlements (Level 3)	88,268,000	86,091,000
Reported Value Measurement [Member] | Fair Value, Inputs, Level 3 [Member]
Consumer receivables acquired for liquidation (Level 3)	9,210,000	13,427,000
Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 1 [Member]
Cash equivalents (Level 1)	2,864,000	923,000
Fair Value	5,500,000	56,764,000
Other investments, net		3,590,000
Structured settlements (Level 3)	88,268,000	86,091,000
Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 3 [Member]
Consumer receivables acquired for liquidation (Level 3)	$ 41,488,000	$ 47,233,000

Note 16 - Fair Value of Finan76

Note 16 - Fair Value of Financial Measurements and Disclosures - Quantitative Information About Level 3 Fair Value Measurements (Details) - Valuation Technique, Discounted Cash Flow [Member]	Jun. 30, 2017USD ($)
Structured Settlements, Fair Value	$ 88,268,000
Rate	0.0605
Minimum [Member] | Measurement Input, Discount Rate [Member]
Rate	0.0471

Note 16 - Fair Value of Finan77

Note 16 - Fair Value of Financial Measurements and Disclosures - Changes in Structured Settlements at Fair Value Using Significant Unobservable Inputs (Details)	9 Months Ended
	Jun. 30, 2017USD ($)
Balance	$ 86,091,000
Fair value adjustment	(433,000)
Total gains and losses included in earnings	(842,000)
Changes in allowance	242,000
Purchases	13,363,000
Sales	(7,727,000)
Interest accreted	4,760,000
Payments received	(7,186,000)
Balance	$ 88,268,000

Note 16 - Fair Value of Finan78

Note 16 - Fair Value of Financial Measurements and Disclosures - Schedule of Realized and Unrealized Gains and Losses (Details)	9 Months Ended
	Jun. 30, 2017USD ($)
The amount of total gains for the nine months period included in earnings attributable to the change in unrealized gains relating to assets held at June 30, 2017	$ 4,511,000
Realized loss relating to assets sold during the nine months ended June 30, 2017	(5,353,000)
Total losses included in the nine months ended June 30, 2017	$ (842,000)

Note 17 - Segment Reporting (De

Note 17 - Segment Reporting (Details Textual)	9 Months Ended
	Jun. 30, 2017USD ($)	Sep. 30, 2016USD ($)	Jun. 30, 2016USD ($)
Number of Reportable Segments	3
Disposal Group, Including Discontinued Operation, Assets, Total	$ 93,692,000	$ 91,506,000
CBC [Member]
Disposal Group, Including Discontinued Operation, Assets, Total	93,692,000	$ 91,506,000
CBC [Member] | Corporate, Non-Segment [Member]
Disposal Group, Including Discontinued Operation, Assets, Total	$ 93,700,000		$ 84,800,000

Note 17 - Segment Reporting - S

Note 17 - Segment Reporting - Schedule of Segment Reporting (Details) - USD ($)		3 Months Ended			9 Months Ended
		Jun. 30, 2017	Jun. 30, 2016		Jun. 30, 2017	Jun. 30, 2016		Sep. 30, 2016
Revenue, Net (Deprecated 2018-01-31)		$ 5,368,000	$ 5,741,000		$ 16,259,000	$ 17,257,000
Other income		100,000	200,000		(100,000)	1,200,000
Segment profit (loss)		1,790,000	5,041,000		(7,064,000)	3,309,000
Segment Assets(1)		212,671,000	246,600,000	[1]	212,671,000	246,600,000	[1]	$ 255,008,000
Operating Segments [Member] | Consumer Receivables [Member]
Revenue, Net (Deprecated 2018-01-31)		4,000,000	4,600,000		12,000,000	14,600,000
Other income
Segment profit (loss)		2,900,000	4,200,000		9,700,000	10,700,000
Segment Assets(1)	[1]	19,600,000	19,200,000		19,600,000	19,200,000
Operating Segments [Member] | GAR Disability Advocates [Member]
Revenue, Net (Deprecated 2018-01-31)		1,100,000	1,200,000		4,000,000	2,700,000
Other income
Segment profit (loss)		0	(1,800,000)		(1,400,000)	(6,300,000)
Segment Assets(1)	[1]	3,300,000	1,500,000		3,300,000	1,500,000
Operating Segments [Member] | Personal Injury Claims [Member]
Revenue, Net (Deprecated 2018-01-31)	[2]	300,000			300,000
Other income	[2]
Segment profit (loss)	[2]	2,600,000	6,200,000		2,300,000	8,000,000
Segment Assets(1)	[1],[2]	52,900,000	45,100,000		52,900,000	45,100,000
Corporate, Non-Segment [Member]
Revenue, Net (Deprecated 2018-01-31)	[3]
Other income	[3]		200,000		(100,000)	1,200,000
Segment profit (loss)	[3]	(3,700,000)	(3,600,000)		(17,700,000)	(9,100,000)
Segment Assets(1)	[1],[3],[4]	$ 136,900,000	$ 180,800,000		$ 136,900,000	$ 180,800,000
[1]	Includes other amounts in other line items on the consolidated balance sheet.
[2]	The Company records Pegasus as an equity investment in its consolidated financial statements. For segment reporting the Company has included its pro-rated share of the earnings and losses from its investment under the Personal Injury Claims segment.
[3]	Corporate is not part of the three reportable segments, as certain expenses and assets are not earmarked to any specific operating segment.
[4]	Included in Corporate are approximately $93.8 million and $84.8 million of assets related to discontinued operations as of June 30, 2017 and 2016, respectively.

Note 18 - Accumulated Other C81

Note 18 - Accumulated Other Comprehensive (Loss) Income - Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Sep. 30, 2016
Balance, September 30, 2016, as previously reported			$ 181,783,000	$ 183,407,000	$ 183,407,000
Change in unrealized (losses) gains on marketable securities, net of tax benefit/ (expense)	$ 18,000	$ 560,000	(17,000)	1,046,000
Net current-period other comprehensive (loss) income	42,000	478,000	(592,000)	970,000
Balance	119,193,000	177,544,000	119,193,000	177,544,000	181,783,000
Net unrealized securities gain (loss), net of tax (expense)/benefit of $(12,000) and ($364,000) during the three month periods ended June 30, 2017 and 2016, respectively, and $11,000 and ($695,000) during the nine month periods ended June 30, 2017 and 2016, respectively.	18,000	560,000	(17,000)	1,046,000
Accumulated Net Investment Gain (Loss) Attributable to Parent [Member]
Balance, September 30, 2016, as previously reported			624,000	(205,000)	(205,000)
Change in unrealized (losses) gains on foreign currency translation, net of tax benefit/(expense) of ($21,000) and $31,000 at June 30 2017, and September 30, 2016, respectively.
Change in unrealized (losses) gains on marketable securities, net of tax benefit/ (expense)			(607,000)	1,046,000	868,000
Amount reclassified from accumulated other comprehensive loss, net of tax benefit			(17,000)	(39,000)	(39,000)
Net current-period other comprehensive (loss) income			(624,000)	1,007,000	829,000
Balance		802,000		802,000	624,000
Change in unrealized (losses) gains on foreign currency translation, net of tax benefit/(expense)
Net unrealized securities gain (loss), net of tax (expense)/benefit of $(12,000) and ($364,000) during the three month periods ended June 30, 2017 and 2016, respectively, and $11,000 and ($695,000) during the nine month periods ended June 30, 2017 and 2016, respectively.			(607,000)	1,046,000	868,000
Amount reclassified from accumulated other comprehensive loss, net of tax benefit			(17,000)	(39,000)	(39,000)
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
Balance, September 30, 2016, as previously reported			179,000	225,000	225,000
Change in unrealized (losses) gains on foreign currency translation, net of tax benefit/(expense) of ($21,000) and $31,000 at June 30 2017, and September 30, 2016, respectively.			32,000	(37,000)	(46,000)
Change in unrealized (losses) gains on marketable securities, net of tax benefit/ (expense)
Amount reclassified from accumulated other comprehensive loss, net of tax benefit
Net current-period other comprehensive (loss) income			32,000	(37,000)	(46,000)
Balance	211,000	188,000	211,000	188,000	179,000
Change in unrealized (losses) gains on foreign currency translation, net of tax benefit/(expense)			32,000	(37,000)	(46,000)
Net unrealized securities gain (loss), net of tax (expense)/benefit of $(12,000) and ($364,000) during the three month periods ended June 30, 2017 and 2016, respectively, and $11,000 and ($695,000) during the nine month periods ended June 30, 2017 and 2016, respectively.
Amount reclassified from accumulated other comprehensive loss, net of tax benefit
AOCI Attributable to Parent [Member]
Balance, September 30, 2016, as previously reported			803,000	20,000	20,000
Change in unrealized (losses) gains on foreign currency translation, net of tax benefit/(expense) of ($21,000) and $31,000 at June 30 2017, and September 30, 2016, respectively.			32,000	(37,000)	(46,000)
Change in unrealized (losses) gains on marketable securities, net of tax benefit/ (expense)			(607,000)	1,046,000	868,000
Amount reclassified from accumulated other comprehensive loss, net of tax benefit			(17,000)	(39,000)	(39,000)
Net current-period other comprehensive (loss) income			(592,000)	970,000	783,000
Balance	$ 211,000	$ 990,000	211,000	990,000	803,000
Change in unrealized (losses) gains on foreign currency translation, net of tax benefit/(expense)			32,000	(37,000)	(46,000)
Net unrealized securities gain (loss), net of tax (expense)/benefit of $(12,000) and ($364,000) during the three month periods ended June 30, 2017 and 2016, respectively, and $11,000 and ($695,000) during the nine month periods ended June 30, 2017 and 2016, respectively.			(607,000)	1,046,000	868,000
Amount reclassified from accumulated other comprehensive loss, net of tax benefit			$ (17,000)	$ (39,000)	$ (39,000)

Note 18 - Accumulated Other C82

Note 18 - Accumulated Other Comprehensive (Loss) Income - Accumulated Other Comprehensive Income (Loss) (Details) (Parentheticals) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Sep. 30, 2016
Unrealized gain (loss) on marketable securities, tax	$ (12,000)	$ (364,000)	$ 404,000	$ (695,000)	$ (529,000)
Reclassified from accumulated other comprehensive loss, tax			11,000		24,000
Unrealized gain (loss) on marketable securities, tax	$ 12,000	$ 364,000	$ (404,000)	695,000	$ 529,000
Accumulated Net Investment Gain (Loss) Attributable to Parent [Member]
Unrealized gain (loss) on marketable securities, tax				695,000
Reclassified from accumulated other comprehensive loss, tax				24,000
Unrealized gain (loss) on foreign currency translation, tax				25,000
Unrealized gain (loss) on marketable securities, tax				$ (695,000)

Note 19 - Related Party Trans83

Note 19 - Related Party Transactions (Details Textual) - USD ($)	Sep. 17, 2015	Jun. 30, 2015	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Sep. 30, 2016
Payments to Acquire Productive Assets, Total					$ 19,000	$ 120,000
Louis Piccolo [Member]
Consulting Agreement Period	2 years
Professional Fees			$ 20,000	$ 20,000	60,000	60,000
Due to Related Parties, Total			0		0		$ 0
Louis Piccolo [Member] | Pegasus Funding LLC [Member]
Related Party Transaction, Amounts of Transaction			33,000	33,000	$ 100,000	100,000
Louis Piccolo [Member] | Pegasus Funding LLC [Member] | Professional Fees Incurred by a Related Party [Member]
Due to Related Parties, Term					6 years
Louis Piccolo [Member] | Pegasus Funding LLC [Member] | Interest Based on Professional Fees [Member]
Related Party Transaction, Rate					4.00%
Louis Piccolo [Member] | Maximum [Member] | Pegasus Funding LLC [Member]
Professional Fees					$ 700,000
Fortress Funding, LLC [Member]
Due to Related Parties, Total			$ 0		0		$ 800,000
Stock Issued During Period, Shares, Purchase of Assets			55,000
Stock Issued During Period, Value, Purchase of Assets			$ 400,000		400,000
Obligation Settlement, Gain (Loss) Recognized			0
Fortress Funding, LLC [Member] | Conversion of Customers From The Acquired Lists [Member]
Payments to Acquire Productive Assets, Total			49,000	$ 32,000	200,000	$ 200,000
Fortress Funding, LLC [Member] | CBC [Member]
Assets Purchase Agreement, Consideration Transferred		$ 500,000
Asset Purchase Agreement, Remaining Amount Owed			$ 600,000		$ 600,000
Fortress Funding, LLC [Member] | CBC [Member] | Conversion of Customers From The Acquired Lists [Member]
Assets Purchase Agreement, Contingent Consideration		$ 1,200,000

Note 20 - Subsequent Events (De

Note 20 - Subsequent Events (Details Textual) - USD ($)	Feb. 28, 2018	Feb. 05, 2018	Jan. 23, 2018	Jan. 12, 2018	Nov. 24, 2017	Nov. 22, 2017	Jun. 30, 2016	Jun. 30, 2017	Nov. 08, 2016	Sep. 30, 2016
Restricted Cash, Total								$ 10,000,000		$ 10,000,000
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests							$ 1,696,000
Subsequent Event [Member]
Dividends Payable, Amount Per Share		$ 5.30
Payments of Dividends, Total	$ 35,000,000
Dividends Payable, Date Declared		Feb. 5, 2018
Dividends Payable, Date to be Paid		Feb. 28, 2018
Dividends Payable, Date of Record		Feb. 16, 2018
Subsequent Event [Member] | Competitor Allaged Former Subsidiary [Member]
Payments for Legal Settlements						$ 500,000
Subsequent Event [Member] | Lawsuit in Montana State Court [Member]
Payments for Legal Settlements					$ 800,000
Subsequent Event [Member] | Global Settlement [Member]
Payments for Legal Settlements			$ 2,300,000
Litigation Settlement, Amount Awarded to Other Party			$ 4,600,000
Pegasus Legal Funding LLC [Member]
Restricted Cash, Total								$ 24,700,000
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners				20.00%					20.00%
Pegasus Legal Funding LLC [Member] | Subsequent Event [Member]
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests				$ 1,800,000